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ABSTRACT 
Endocytic membrane trafficking is a basic cell process that is critical for 
regulating the transport of lipids and proteins. Our lab focuses on the cellular functions 
and mechanisms of the proteins that regulate these pathways. A key family of 
regulatory proteins is the C-terminal Eps15 Homology Domain (EHD) protein family. 
The EHD family includes EHD1-4, which are ubiquitously expressed in mammalian 
tissues. While these isoforms do have some overlapping functions, each protein also has 
distinct activities in regulating the shape and fission of membranes throughout the 
endocytic pathways. Specifically, EHD1 uses ATP hydrolysis to induce constriction and 
fission of endocytic membranes. EHD1 is recruited to tubular recycling endosomes 
(TREs) by interacting with Molecules Interacting with CAsL-Like 1 (MICAL-L1) and it 
performs fission to release cargo-containing vesicles from the TRE. Our lab 
demonstrated that upon EHD1 depletion, the TREs become elongated due to the lack of 
fission and the receptors that recycle through this pathway display impaired recycling to 
the plasma membrane. Furthermore, our lab and others have shown that EHD1 not only 
interacts with MICAL-L1, but also with a variety of other proteins, such as the retromer 
cargo selection complex (CSC), which is known to regulate the trafficking of membranes 
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and proteins between endosomes and the Golgi complex. Recently, the proposed role of 
VPS35, a core protein of the retromer complex, has expanded, and it was found to 
interact with and control the mitochondrial fission protein, Drp1. However, the 
connection between EHD1 and the retromer and their role in mitochondrial homeostasis 
is less clear. It was previously thought that endocytic regulatory proteins exclusively 
impacted membrane trafficking pathways, but recent studies suggest that endocytic 
regulatory proteins play a role in many other pathways including ciliogenesis, 
centrosome disengagement, and mitochondrial homeostasis. Herein, I describe a novel 
role for in endocytic regulatory proteins in controlling mitochondrial fission and 
mitochondrial-induced apoptosis. My studies led to a model by which EHD1 regulates 
the localization of the retromer within the cell; accordingly, when EHD1 is absent, the 
retromer no longer regulates the mitochondrial fission protein, Drp1. In addition, I 
demonstrate for the first time, a connection between endocytic proteins and apoptosis by 
proposing a model for an expanded role for the retromer complex in regulating 
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1. ENDOCYTIC TRAFFICKING 
1.1 Overview 
The plasma membrane (PM) is a lipid bilayer that forms a permeable barrier 
between the intracellular components of a cell and the extracellular environment 
(Conner & Schmid, 2003). The PM not only is responsible for the regulation of what 
comes in and out of the cell, such as ions or other various molecules, but also mediates 
the communication between neighboring cells, and has the ability to receive the 
extracellular cues needed for growth and survival. The dynamic connection between 
endocytic trafficking and endocytic events is critical for regulating and maintaining the 
surface area and protein composition of the PM (G. J. Doherty & McMahon, 2009). 
 Endocytic membrane trafficking refers to the process by which internalization of 
receptors, proteins, and nutrients along with extracellular fluid is enclosed in an 
invaginated portion of the PM, resulting in the pinching off of the membrane to form an 
endosome or vesicle (Conner & Schmid, 2003). Vesicle formation at the PM can occur 
through two distinct pathways, termed clathrin-dependent or clathrin-independent 
(described later in detail). No matter which way the lipids and proteins are internalized, 
the cargos are packaged into vesicles and delivered to an organelle, known as the early 
endosome (EE) or sorting endosome (SE) (Mayor, Presley, & Maxfield, 1993; Mellman, 
1996a), where the cargo is initially sorted to determine its final fate. From the EE, the 
cargo can be destined for degradation by being transported to late endosomes (LE) and 
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eventually the lysosomes, the cargo can be recycled back to the PM, or transported to 
trans-Golgi network (TGN). (Figure 1.1) 
 Endocytic trafficking plays a crucial role in regulating many diverse cellular 
processes, including the uptake of nutrients, regulation of surface receptors, cellular 
signaling, cytokinesis (Conner & Schmid, 2003; Skop, Bergmann, Mohler, & White, 
2001), maintenance of cell polarity, cell adhesion and cell migration (Caswell & Norman, 
2008; E. Wang et al., 2000), and synaptic vesicle retrieval in neurons (Kjaerulff, 
Verstreken, & Bellen, 2002).  Dysregulation of the endocytic pathways have been related 
to various diseases, such as different types of cancer, neurodegeneration, and heart 
disease (Conner & Schmid, 2003; Stein, Dong, & Wandinger-Ness, 2003). Additionally, 
studies have shown that pathogens can exploit distinct endocytic pathways in order for 
the host cell to internalize the pathogen more efficiently (Mercer et al., 2010). 
Understanding the mechanisms that regulate endocytic pathways will ultimately 
provide novel approaches for developing therapeutic strategies and drug development.  
1.2 Modes of internalization 
Internalization into a cell can occur through multiple pathways and is largely 
determined by the size of the molecule or particle that needs to be internalized. For 
example, smaller molecules like amino acids, sugars, and ions can enter through 
channels and protein pumps embedded into the PM. However, the macromolecules that 
are unable to fit through these channels or pumps undergo endocytosis through the 






Overview of endocytic pathways. Once internalized from the plasma membrane, 
membrane-bound vesicles that carry receptors from the cell surface fuse with the 
EEs. The EE serves as a sorting station from which either tubulo-vesicular carriers 
deliver cargo to the endo-lysosomal system for degradation, or cargos are recycled 
directly or indirectly to the plasma membrane via the endocytic recycling 
compartment. Used with permission from JCS (Naslavsky & Caplan, 2018). 
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based on the size of the internalized endocytic vesicle, phagocytosis or pinocytosis. 
Phagocytosis includes the internalization of larger molecules, such as microbial 
pathogens or cellular debris (Aderem & Underhill, 1999), while pinocytosis includes the 
internalization of fluid and low-molecular-weight solutes (Conner & Schmid, 2003). 
Pinocytosis can be further broken down into two categories based on the type of 
machinery that is needed at the PM during internalization, clathrin-mediated 
endocytosis (CME) (Figure 1.1) or clathrin-independent endocytosis (CIE). Furthermore, 
CIE can be subdivided into different types depending on whether caveolae is present 
(Conner & Schmid, 2003; Mayor & Pagano, 2007; Mayor, Parton, & Donaldson, 2014).  
1.2.1 Clathrin-mediated endocytosis (CME) 
  CME is the most extensively studied pathway of internalization from the PM. 
The founding discoveries of clathrin and clathrin-coated vesicles (CCVs) have shaped 
the way we currently think about CME (Pearse & Crowther, 1987). Over the last few 
decades, the work of many scientists has shed light on the mechanism by which 
receptors bound to their ligands at the PM are internalized into clathrin-coated pits 
(CCPs) and eventually form the CCVs (Robinson, 2015; Sorkin, 2004). The formation of 
CCVs can be divided into a five-stage process: initiation, cargo selection, coat assembly, 
scission, and uncoating. Key to the formation of CCPs and CCVs is the clathrin itself. 
During formation of CCPs, the clathrin is unable to bind to the membrane directly and 
instead forms a scaffold to recruit a diverse array of clathrin-associated proteins to 
complete the downstream internalization events. One key protein that is recruited to the 
PM before the assembly of CCPs is Adaptor Protein-2 (AP-2), which acts as a hub for 
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interactions between both the cargo and the PM. AP-2 is a complex composed of two 
large adaptin subunits-α and β2, one medium-μ2 and one small σ2 subunit (Owen, 
Collins, & Evans, 2004). The AP-2 complex is able to recognize two types of motifs on 
the cytoplasmic tail of receptors or cargo: 1) tyrosine-based motifs with a consensus 
sequence YXXΦ, where Y is a tyrosine residue, X stands for any amino acid residue and 
Φ is a bulky hydrophobic amino acid residue, and 2) the dileucine-based sorting signals 
with a consensus sequence defined by DXXLL and [DE]XXXL[LI] with D being 
aspartate, E being glutamate, L being leucine, and I being isoleucine (Bonifacino & 
Traub, 2003; Janvier et al., 2003). The binding site for the tyrosine-based motifs is on the 
carboxyl terminus of the μ2 domain (Ohno et al., 1995), while the α/σ2 hemi-complex 
and potential β2 subunit bind to the dileucine-based sorting signal sequence 
(Chaudhuri, Lindwasser, Smith, Hurley, & Bonifacino, 2007; Doray, Lee, Knisely, Bu, & 
Kornfeld, 2007). Along with the AP-2 protein are other specialized adaptor proteins 
known as clathrin-associated sorting proteins (CLASPs), that recognize diverse sorting 
signals on the respective cargo receptors, thus facilitating a large range of distinct cargos 
that can be endocytosed (Traub & Bonifacino, 2013). Furthermore, post-translational 
modifications such as phosphorylation and ubiquitination can recruit CLASPs to 
receptor tails. Once the cargo is selected and packaged by AP-2 and CLASPs, the 
assembly of the clathrin coat is initiated. AP-2 and the accessory proteins recruit clathrin 
to the site of internalization at the PM. Clathrin is a trimer of dimers consisting of three 
heavy chains and three light chains assembled as a triskelion that has the intrinsic ability 
to build a cage-like structure upon invagination of the PM (Kirchhausen, 2000). Once the 
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clathrin is recruited to the PM and the cage-like structure begins to form, more accessory 
proteins are recruited to generate and stabilize the curvature of the maturing CCPs, such 
as the Bin-Amphiphysin-Rvs (BAR) containing proteins (Koch, Westermann, Kessels, & 
Qualmann, 2012). Towards the end of the formation of the CCP, a large and modular 
guanosine tri-phosphatase (GTPase) known as Dynamin, along with other curvature 
sensing proteins including Amphiphysin, Endophilins, and Sorting Nexin (SNX) 9 
(SNX9), facilitates the release of CCVs from CCPs (A. Lee, Frank, Marks, & Lemmon, 
1999; Vallis, Wigge, Marks, Evans, & McMahon, 1999; van der Bliek et al., 1993; Yoshida 
et al., 2004). The Dynamin GTPase oligomerizes around the neck of the CCPs in a collar-
like structure and catalyzes guanosine tri-phosphate (GTP) hydrolysis to mediate 
membrane fission and generate independent CCVs. After the scission of the CCV from 
the PM, the clathrin coat around the vesicle is disassembled by an adenosine tri-
phosphatase (ATPase) known as Heat shock cognate 70 (Hsc70) and its co-factor 
Auxillin (Braell, Schlossman, Schmid, & Rothman, 1984; Prasad, Barouch, Greene, & 
Eisenberg, 1993; Ungewickell, 1999). The low-density lipoprotein (LDL) receptor and the 
iron-laden transferrin receptor (TfR) are examples of signature cargo that are 
internalized by CME. (Figure 1.1) 
1.2.2 Clathrin-Independent Endocytosis (CIE) 
 It is thought that CME is the dominant pathway of internalization of cargo into 
the cell, however cells are able to utilize a variety of non-CME pathways collectively 
termed CIE. A common theme connecting the CIE pathways is the need for a high 
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concentration of cholesterol at the PM upon invagination (Mayor & Pagano, 2007; 
Sandvig & van Deurs, 1994). 
 The caveolae-mediated pathway is the most well-known CIE pathway. The 
invaginations formed by caveolae are a flask-shape anywhere from 50-100 nm in size. 
These invaginations are usually concentrated at the PM in micro-domains containing 
cholesterol, sphingolipids, and phosphatidylinositol (4,5)-bisphosphate (PIP2) 
(Anderson, 1998; Pitto et al., 2000; Simone, Caplan, & Naslavsky, 2013). Caveolin-1 is a 
crucial membrane protein that oligomerizes to form a loop and inserts into the micro-
domain of the PM in order to form the framework for the flask-shaped membrane that 
comprises the caveolae. Once the Caveolin-1 inserts itself into the PM, it recruits cavin 
proteins (cavin 1-4), which in turn help stabilize and build the budding caveolar vesicle 
(Hansen, Bright, Howard, & Nichols, 2009; Hill et al., 2008). In addition to Caveolin-1 
and the cavin proteins, Syndapin2 (also known as Pacsin2), is recruited to the 
invagination. Syndapin2 is a BAR domain-containing protein that can regulate 
membrane curvature and helps shape the caveolar invagination (Koch et al., 2012; Senju, 
Itoh, Takano, Hamada, & Suetsugu, 2011). Syndapin2 also has a Src homology 3 (SH3) 
domain that allows it to bind the proline-rich domain (PRD) of the dynamin GTPase and 
a tripeptide sequence containing asparagine-proline-phenylalanine (NPF) motif that 
facilitates the binding of Syndapin2 with C-terminal Eps15 homology domain containing 
(EHD) protein 2 (EHD2). EHD2 is required for caveolar stabilization at the PM but 
previous studies in our lab have shown that whereas Syndapin2 is not required for 
EHD2 recruitment, PIP2 levels in the PM are critical for recruitment (Moren et al., 2012; 
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Simone et al., 2013; Stoeber et al., 2012). Certain cell types, such as smooth muscle cells, 
fibroblast, adipocytes, and endothelial cells, are enriched in caveolae-associated 
invaginations (Parton & Simons, 2007). Some examples of the cargo that can be 
internalized through the caveolae-mediated pathway include simian virus 40 (SV40) 
virions, cholera toxin β subunit (CTxβ), and glycosylphosphatidylinositol (GPI)-linked 
proteins (Cheng, Singh, Marks, & Pagano, 2006; Parton & Simons, 2007). 
1.2.3 Clathrin-Independent Carriers/GPI-AP-enriched early endosomal compartment 
(GLIC/GEEC) 
 Proteins that are secured to the PM by GPI-anchor-linked proteins (GPI-AP) do 
not depend on clathrin or caveolin coats to be internalized but they still require the 
cholesterol enriched micro-domains that can be found at the PM (Lakhan, Sabharanjak, 
& De, 2009). GPI-APs are internalized through EE-like structures that are highly 
enriched in GPI-AP. These EE-like structures are called GPI-AP-enriched early 
endosomal compartments (GEEC). The GEECs are formed by the fusion process 
between cell surface-derived clathrin-independent tubulovesicular intermediates termed 
CLICs (Kirkham et al., 2005). In order to form CLICs, two small GTPases must be 
present: cell cycle dependent 42 (Cdc42) and adenosine di-phosphate (ADP)-ribosylation 
factor 1 (Arf1) (Kumari & Mayor, 2008). Unlike the pathways mentioned previously, 
these structures are dynamin-independent and the mechanism of budding in these 
vesicles remains unclear. However, recently a marker of these CLICs was identified as a 
protein called GTPase regulator associated with focal adhesion kinase-1 (GRAF1). 
GRAF1 has distinct domains that are critical for generating CLICs, such as a scission-
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BAR domain for membrane curving, a pleckstrin homology (PH) domain that allows 
GRAF1 to directly bind to PIP2 in the PM, and an SH3 domain that can bind to the PRD 
of dynamin (Lundmark et al., 2008). Additionally, work from our lab has provided 
evidence for a model suggesting that GRAF1 forms a vesiculation complex that is 
comprised of Molecules Interacting with CAsL-Like 1 (MICAL-L1) and C-terminal 
Eps15 homology domain containing (EHD) protein 1 (EHD1) on tubular recycling 
endosomes (TRE), which in turn helps support TRE vesiculation (Cai, Caplan, & 
Naslavsky, 2012; Cai, Xie, Caplan, & Naslavsky, 2014). This may suggest that a 
vesiculation complex generated by GRAF1 could be the potential vesiculator of CLICs. 
GPI-APs, CTxβ, and fluid phase markers are some examples of known cargos that go 
through this pathway (Mayor & Pagano, 2007) (G. J. Doherty & McMahon, 2009). 
1.2.4 Arf6 mediated pathway 
 Another pathway considered to be clathrin-independent is associated with the 
ATPase, ADP-ribosylation factor 6 (Arf6). Arf6 can be found at the PM where it 
regulates the rate of trafficking in and out of the cell as well as the dynamics of the actin 
cytoskeleton near the PM. The mechanism for Arf6 regulation of internalization is by 
activating phosphatidylinositol 4,5 kinase (PI5K), which in turn generates PIP2 at the 
PM, resulting in enriched PIP2 budding vesicles. Since Arf6 stimulates the production of 
PIP2, the latter is able to activate the machinery needed for actin polymerization, thus 
driving the endocytic pathway. GPI-APs, CD59, CD55, and major histocompatibility 
complex class I (MHC I) proteins are cargo known to internalize through this pathway 
(Naslavsky, Weigert, & Donaldson, 2003). 
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1.2.5 CIE of interleukin-2 receptor 
 Another less common CIE pathway is the mechanism used to internalize the 
interleukin-2 (IL-2) receptor. IL-2 concentration and internalization occurs through a 
small non-coated invagination that depends on RhoA and consequently ras-related C3 
botulinum toxin substrate 1 (Rac1) (Gesbert, Sauvonnet, & Dautry-Varsat, 2004; Lamaze 
et al., 2001; Mayor et al., 2014). Internalization of IL-2 occurs in detergent-resistant 
microdomains of the PM and requires dynamin as well as proteins that regulate actin 
polymerization, such as phosphatidylinositol 3-kinase (PI3K), Rac1, Rac1’s guanine 
exchange factor Vav2, kinases Pak1 and Pak2, endocytic adaptor cortactin, and Arp2/3 
stimulator N-WASP (Basquin et al., 2013; Basquin & Sauvonnet, 2013; Grassart, 
Dujeancourt, Lazarow, Dautry-Varsat, & Sauvonnet, 2008; Lamaze et al., 2001). PI3K 
plays a key role as its regulatory subunit, p85, associates with the IL-2 receptor and 
activates the recruitment of its catalytic p110 subunit to produce PI(3,4,5)P3 
(Cendrowski, Maminska, & Miaczynska, 2016). This induces that activation of Rac1 by 
Vav2, which in turn is recruited to the IL-2 receptor that is bound to the PI3K and 
stimulates Pak1 and Pak2 kinases (Cendrowski et al., 2016). The kinases promote actin 
polymerization through cortactin and N-Wasp (Basquin & Sauvonnet, 2013). The 
activation of these proteins likely occurs at the last step of internalization and is critical 
for vesicle scission from the PM. 
1.3 Sorting at the Early Endosome (EE)/Sorting Endosome (SE) 
 The EE is responsible for receiving vesicles from the PM so that cargo can be 
sorted and directed to the correct cellular destination (Jovic, Sharma, Rahajeng, & 
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Caplan, 2010). While many proteins localize to EE and are required for proper function, 
Rab5, a member of the Ras-associated binding (Rab) small GTPases, marks EE and 
controls the function, dynamics, and subsequent organelle transport of EE (Woodman, 
2000). Active Rab5 or GTP-bound Rab5 recruits a number of Rab5 effectors that include 
the phosphatidyl inositol-4-5 bisphosphate-3-kinase (PI3K), promoting the generation of 
phosphoinositol 4-phosphate (PI3P) at the EE. PI3P in the EE membrane allows 
recruitment of proteins that contain a FYVE domain (Stenmark, Aasland, & Driscoll, 
2002). Examples of FYVE domain-containing proteins include Early Endosomal 
Autoantigen-1 (EEA1), Rabankyrin-5, and Rabenoysn-5, which also interact with Rab5 
(Grosshans, Ortiz, & Novick, 2006), suggesting that more than a single mechanism exists 
to recruit these proteins to the EE.  
EE have a mildly acidic lumen between pH 6.3-6.5 and the acidity is important 
for disrupting the coupling between the ligands and their receptors within the first few 
moments of internalization. This uncoupling of the ligand from the receptor is the first 
step in cargo sorting (Maxfield & McGraw, 2004). Additionally, the Rab-5-dependent 
recruitment of a diverse number of effector proteins encourages the differentiation of the 
EE from a small vesicular structure to a rather large structure that has both a vacuolar 
and tubular component to it (Huotari & Helenius, 2011). This differentiation is due to 
the fact that EE are highly dynamic and undergo homotypic fusion (Gruenberg et al. 
1989). The formation of both vacuolar and tubular components provides subdomains 
within the EE that allow for efficient sorting of cargos  (Mayor et al., 1993). For example, 
cargo clustered in the tubular areas of the EE is usually targeted for recycling back to the 
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PM, whereas cargo inside the more bulky vesicles is usually sent to the lysosome for 
degradation by way of multi-vesicular bodies (MVBs) (Mellman, 1996b). Frequently, the 
internalized receptor is recycled back to the PM to bind with another ligand, while the 
ligand is transported to the lysosome for degradation (Maxfield & McGraw, 2004). For 
instance, TfR and LDL receptors are recycled back to the PM upon entering the EE, 
while the transferin (Tf) and LDL itself are transported to the lysosome for degradation 
(Jovic, Kieken, Naslavsky, Sorgen, & Caplan, 2009). (Figure 1.1) 
1.4 Sorting cargos to the LE/lysosome for degradation 
 As previously mentioned above, the EE is responsible for regulating the sorting 
of ligands and signaling receptors that have been internalized from the PM. The ligands 
that have uncoupled from their receptors and become soluble are typically sorted for 
degradation by a maturation pathway beginning with EE and advancing to LE. 
However, the transmembrane receptors must be sorted by their sorting signals located 
in the cytosolic domain of the receptor. A frequently studied receptor is the Epidermal 
Growth Factor Receptor (EGFR), a tyrosine kinase (RTK) that has a specific cytosolic 
domain recognized by sorting machinery that targets it to the degradation pathway 
(Haglund et al., 2003). The sorting of the EGFR is done by post-translational 
ubiquitination of one or more of the lysine residues in its cytoplasmic tail, in turn 
marking it for degradation through the lysosome (Haglund et al., 2003; Huang, 
Kirkpatrick, Jiang, Gygi, & Sorkin, 2006; Levkowitz et al., 1998; Umebayashi, Stenmark, 
& Yoshimori, 2008). Once the receptor is marked with ubiquitin, several proteins that 
interact with ubiquitin through ubiquitin-interacting motifs (UIM) recognize the 
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receptor. These proteins include the endosomal sorting complexes required for 
transport-0 (ESCRT-0), hepatocyte growth factor regulated tyrosine kinase substrate 
(Hrs), signal transducing adaptor molecule 2 (STAM2) and the ESCRT-I component, and 
tumor susceptibility gene 101 (TSG101) (Raiborg & Stenmark, 2002). In parallel, the 
ESCRT-1 component and Tsg101 promote the recruitment of the ESCRT-II complex. This 
event is needed to initiate the budding of MVBs. The ESCRT-II triggers the 
oligomerization of the ESCRT-III complex on the endosomal membrane, which allows 
for the capture of the cargo to novel MVB and also catalyzes the scission of the MVB 
(Babst, Katzmann, Estepa-Sabal, Meerloo, & Emr, 2002; Babst, Katzmann, Snyder, 
Wendland, & Emr, 2002). Upon completion of MVB formation, vacuolar sorting protein 
(VPS) 4 (VPS4), an ATPase, is recruited to catalyze the disassembly of the ESCRT-III 
complex from the newly formed MVB. The newly formed MVB can then fuse with the 
LE or lysosome, resulting in the degradation of the EGFR and other sorted receptors 
(Shestakova et al., 2010). Our lab has been able to establish a novel role for C-terminal 
Eps15 homology domain containing (EHD) protein 4 (EHD4) in the trafficking of 
receptors from the EE to the lysosomes (Sharma, Naslavsky, & Caplan, 2008). 
1.5 Sorting cargos for recycling back to the PM 
 Cargos that are selected to return back to the PM can do so via two routes. The 
first route is through the “fast recycling” pathway. Fast recycling refers to the recycling 
of receptors back to the PM directly from the EE. However, most of the receptors travel 
from the EE to an additional organelle termed the endocytic recycling compartment 
(ERC). The ERC is localized near the microtubule organizing center (MTOC) in the 
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perinuclear area of the cell (B. D. Grant & Donaldson, 2009; Maxfield & McGraw, 2004). 
Rab4 and Rab11 are the most prominent markers for differentiating between the fast and 
slow recycling pathways, respectively (Ullrich, Reinsch, Urbe, Zerial, & Parton, 1996; 
Van Der Sluijs et al., 1991).  
The composition, structure, and functional mechanism of the ERC in endocytic 
recycling are poorly understood despite the importance of the ERC in the recycling 
process. Recent studies from our lab took advantage of super resolution microscopy, 
Structured Illumination Microscopy (SIM), dual channel 2D-direct Stochastic Optical 
Reconstruction Microscopy (dSTORM), and 3D STORM, in order to address ERC 
morphology and cargo selection. The studies showed that the ERC is composed of an 
array of dynamic, densely situated but independent tubular and vesicular recycling 
endosomes coming from the MTOC (Xie et al., 2016). It has been established that due to 
the high surface area-to-volume ratio displayed in the ERC, this facilitates segregation of 
the integral membrane protein cargo from their luminal content (Maxfield & McGraw, 
2004). However, studies in our lab show that the ERC maintains cargo separation that 
has occurred in the EE, suggesting that the ERC serves as a focal point for vesicular 
transport to the PM (Xie et al., 2016).  
TREs, found within the ERC, are critical for the recycling of internalized receptors and 
lipids. Previous studies from our lab have shown that MICAL-L1-decorated TREs can be 
generated from areas of the EE that are enriched in a Rab-5 effector known as 
Rabenosyn-5 (Xie et al., 2016). Furthermore, our lab’s current model suggests that the 
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fission of TREs leads to the formation of vesicle carriers that transport the receptor back 
to the PM (Cai et al., 2012; Cai et al., 2013; Cai et al., 2014). Adding to the significance of 
TREs, our lab as extensively studied the players involved in TRE generation, fission, 
fusion, and function. Previous studies from our lab have been able to demonstrate that 
MICAL-L1 localizes to TRE (Sharma, Jovic, et al., 2009) and acts as a hub that recruits 
and stabilizes multiple proteins that can impact the shape of the TREs. For example, the 
F-BAR domain containing protein Syndapin2 interacts with MICAL-L1 and bends 
endosomal membranes to generate TREs (Giridharan, Cai, Vitale, Naslavsky, & Caplan, 
2013). MICAL-L1 also interacts with the C-terminal Eps15 homology domain containing 
(EHD) protein 3 (EHD3) and EHD1 (Kieken et al., 2010; Sharma, Jovic, et al., 2009). 
EHD3 and EHD1 are responsible for the stabilization and vesiculation of the TREs, 
respectively (Bahl et al., 2016; Cai et al., 2013). Another critical aspect to TREs is the high 
concentration of phosphatidic acid (PA), an essential lipid component of the TRE 
membrane that allows for the binding with MICAL-L1 and Syndapin2. EHD1 
subsequently binds to the MICAL-L1 and Syndapin2 complex on the TRE, and induces 
scission of these membranes, generating a newly synthesized vesicle (Cai et al., 2013; Cai 
et al., 2014; Giridharan et al., 2013). (Figure 1.2) 
1.6 Sorted cargos destined for the trans-Golgi network (TGN)   
EEs are not only important for sorting receptors and ligands to the recycling or 
degradation pathway but are also important for the tethering of various endocytic and 
biosynthetic pathways. Transport from the EE to the TGN is known as retrograde 





Model for biogenesis of tubular recycling endosomes. (A) Phosphatidic acid is 
generated or enriched on membranes. (B) MICAL-L1 (via its CC domain) and Synd2 
(via its F-BAR domain) are recruited to PA-enriched membranes. (C) The MICAL-L1 
PXXP motifs interact with the SH3 domain of Synd2 to stabilize both proteins on the 
membranes and (D) facilitate the generation of tubular endosomes by Synd2. (E) 
Synd2 and MICAL-L1 bind to the EH domain of EHD1 via their NPF motifs and 
recruit EHD1 to these tubular membranes, potentially facilitating vesiculation. Used 




transport, these tubules are distinct from the TREs that facilitate the recycling process 
previously described (Bonifacino & Rojas, 2006). The machinery that is necessary for 
retrograde transport is recruited to EEs that are in the process of maturation and 
evolving into LE and therefore contain a higher concentration of phosphatidylinositol 
3,5, bisphosphate (PI(3,5)P2) and have an increasing number of intraluminal vesicles 
(ILVs). 
 Initial studies by Seaman and coworkers in the yeast endolysosomal system were 
instrumental in the identification of the protein complex called the “retromer” (Seaman, 
McCaffery, & Emr, 1998). The retromer was proposed to mediate the endosome-to-TGN 
retrieval of the vacuolar hydrolase receptor, Vps10p, which is the yeast equivalent of the 
mannose 6-phosphate (M6PR) receptor. The retromer consists of a hetero-pentameric 
complex consisting of a SNX dimer composed of SNX1/2 or Snx5/6 and a trimer 
consisting of vacuolar protein sorting 35 (VPS35), vacuolar protein sorting 26 (VPS26), 
and vacuolar protein sorting 29 (VPS29) (Bonifacino & Hurley, 2008; Bonifacino & Rojas, 
2006; Rojas et al., 2008; Seaman, 2005). Initially the trimer of VPS35, VPS26, and VPS29 
was thought to be involved in the cargo sorting, while the SNX dimer was responsible 
for binding to the EE membrane by the phox-homology (PX) domain contained within 
the SNX proteins, therefore acting as a scaffold (Bonifacino & Rojas, 2006). However, the 
structure of the retromer complex has recently been described using cryo-elctron 
tomography and subtomogram averaging to highlight the retromer as a structure that 
forms arches that extend away from the membrane surface (Kovtun et al., 2018). Based 
on these structures, it is thought that the trimer of VPS proteins forms a scaffold and the 
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distinct combination of SNX proteins associated with the retromer controls the cargo 
sorting function (Kovtun et al., 2018). While the exact mechanism detailing how the 
retromer sorts cargo destined for the TGN is yet to be determined, it has been 
established that the cargo within these endosomes contain at least one simple 
hydrophobic motif comprised of phenylalanine/tryptophan-leucine-methionine/valine 
(F/W-L-M/V) (Gokool, Tattersall, & Seaman, 2007). The most well studied cargos that are 
transported through the retrograde transport include the vacuolar hydrolase transport 
receptors, VPS10 in yeast or M6PR in mammals (Bonifacino & Rojas, 2006; Johannes & 
Popoff, 2008). 
 EHD1 is also an important regulator of the retromer-mediated transport of 
cargos from EEs to the TGN. EHD1 co-localizes and interacts with the VPS26 and VPS35 
subunits of the retromer and impacts the retrieval of the M6PR back to the TGN (Gokool 
et al., 2007). While we have observed co-localization and interactions between EHD1, 
VPS35, and VPS26, it has yet to be determined if this interaction is direct or indirect. 
However, work from our lab suggests that Rabankyrin-5, a Rab5 effector that binds 
directly to EHD1 through a MPF motif, also interacts with the retromer complex, 
potentially mediating the interaction between EHD1 and the retromer (McKenzie et al., 
2012; Zhang, Naslavsky, & Caplan, 2012; Zhang, Reiling, et al., 2012). It is also important 
to note that our lab found EHD3, the closest paralog of EHD1, mediates the transport of 
cargo from the EE to TGN (Naslavsky, McKenzie, Altan-Bonnet, Sheff, & Caplan, 2009). 
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2. REGULATORS OF ENDOCYTIC TRAFFICKING 
2.1 Overview 
 Endocytic trafficking of cargos is very important and critical function for the cell 
to maintain homeostasis; therefore the process is highly regulated by multiple types of 
proteins, such as Rab GTPases, soluble N-ethylmaleimide-sensitive factor attachment 
protein receptors (SNARE) fusion machinery proteins, fission proteins such as EHD1, 
coat proteins, and many more. These proteins work together to actively internalize, sort, 
degrade, and recycle internalized cargo.  
 Rab GTPases are a family of more than 60 small Ras-related GTP-binding 
proteins that control endocytic trafficking steps and localize to the endocytic organelles, 
such as the EE or LE (Pfeffer & Aivazian, 2004). When a Rab is bound to GDP, the Rab 
usually becomes cytosolic and inactive, while GTP-bound Rabs are usually active and 
bound to the endocytic membranes. When Rab proteins are bound to the endocytic 
membranes they are able to recruit Rab effector proteins that regulate the membrane 
lipid content, membrane fusion/fission, and transport along the cytoskeleton (Pfeffer & 
Aivazian, 2004).  
 Another class of proteins that is critical for the transport of vesicles from one 
destination to another in the endocytic pathway is the SNARE family of proteins. 
SNARE proteins located on the vesicle are termed v-SNAREs and the vesicles target 
membrane are termed t-SNAREs. Together, the v-SNARE and t-SNARE provide the 
required energy for the fusion of the transport vesicle and the target membrane.  
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 The EHD family of proteins consists of four highly homologous membrane-
associated ATPases that are able to regulate membrane tubule and vesicle formation by 
means of their interaction partners. It has been well documented that if these EHD 
proteins are depleted or mutated, cargos are not efficiently transported between 
endocytic compartments (Naslavsky & Caplan, 2011). While the EHD1-4 family of 
proteins shares high sequence homology, each protein retains separate functionality in 
its regulation of the endocytic pathway.  
2.2. Rab GTPases and their effector proteins 
 Among the various proteins needed to regulate endocytic trafficking, the small 
Rab proteins play a major role. During a Rab GTPase cycle, the GDP-bound Rab protein 
is considered inactive and associates with Guanosine nucleotide dissociation inhibitors 
(GDIs), which are located in the cytosol. In order for the Rab to unbind from the GDI in 
the cytosol, a GDI displacement factor (GDF) must release the Rab so it can be recruited 
to the endocytic membrane. Once the Rab becomes GTP-bound, it interacts with a series 
of specific protein effectors that include but are not limited to tethering molecules, 
kinases, phosphatases, adaptor proteins, and motor proteins that help the Rab carry out 
its function of fission, fusion, and tethering. A GTP-bound Rab can become inactive and 
disassociate from endocytic membranes by its specific GTPase-activating proteins 
(GAPs). GAPs work by facilitating GTP hydrolysis, making the Rab become GDP-bound 
and completing the Rab cycle. (Figure 1.3) 
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 The Rab proteins that are associated with the EE mediate the function of post- 
internalization sorting and include Rab4, Rab5, Rab10, Rab11, and Rab22 (Babbey et al., 
2006; Magadan, Barbieri, Mesa, Stahl, & Mayorga, 2006; Van Der Sluijs et al., 1991). As 
mentioned previously, Rab5 is the most extensively studied Rab on EE and commonly 
used as a marker of this organelle. (Barbieri, Roberts, Mukhopadhyay, & Stahl, 1996; 
Bucci et al., 1992; Gorvel, Chavrier, Zerial, & Gruenberg, 1991; Grosshans et al., 2006; 
Zerial & McBride, 2001). It is thought that Rab5 controls trafficking by regulating the 
composition of the membrane to include more PI3P (Christoforidis et al., 1999; Murray, 
Panaretou, Stenmark, Miaczynska, & Backer, 2002), promoting homotypic fusion 
(Gorvel et al., 1991) and facilitating the EE on cytoskeletal tracks (Nielsen, Severin, 
Backer, Hyman, & Zerial, 1999; Pal, Severin, Lommer, Shevchenko, & Zerial, 2006). For 
the Rab5 to become active and GTP-bound, the guanine exchange factor (GEF), Rabex-5, 
must be present at the EE to activate Rab5 (Horiuchi et al., 1997). GTP-bound Rab5 
recruits Rab5 effector proteins to the membrane of the EE, where their specialized 
function in the sorting or trafficking of cargos can take place (Grosshans et al., 2006). 
Some of the key Rab5 effectors include PI3K (Christoforidis et al., 1999), EEA1 
(Merithew, Stone, Eathiraj, & Lambright, 2003), Rabenosyn-5 (Nielsen et al., 2000) and 
Adaptor protein containing PH domain (APPL1 and APPL2) (Miaczynska et al., 2004). 
The PI3K leads to increased PIP2 in the endocytic membrane, which allows the 




Figure 1. 3 
The Rab switch and its circuitry. Conversion of the GDP-bound Rab into the GTP-
bound form occurs through the exchange of GDP for GTP, which is catalysed by a 
guanine nucleotide exchange factor (GEF) and causes a conformational change. The 
GTP-bound 'active' conformation is recognized by multiple effector proteins and is 
converted back to the GDP-bound 'inactive' form through hydrolysis of GTP, which 
is stimulated by a GTPase-activating protein (GAP) and releases an inorganic 
phosphate (Pi). The newly synthesized Rab, in the GDP-bound form, is recognized 
by a Rab escort protein (REP). The REP presents the Rab to a geranylgeranyl 
transferase (GGT), which geranylgeranylates the Rab on one or two carboxy-terminal 
Cys residues. The geranylgeranylated, GDP-bound Rab is recognized by Rab GDP 
dissociation inhibitor (GDI), which regulates the membrane cycle of the Rab. 
Targeting of the Rab–GDI complex to specific membranes is mediated by interaction 
with a membrane-bound GDI displacement factor (GDF). Used with permission from 




Rabenosyn-5 both bind to PI3P in the membrane through their FYVE domain. EEA1 
subsequently recruits Syntaxin13 and Syntaxin6, which facilitate EE fusion with other 
endocytic membranes later in the pathway (McBride et al., 1999; Simonsen, Gaullier, 
D'Arrigo, & Stenmark, 1999). Rabenosyn-5 on the endocytic membrane binds human 
vacuolar protein sorting 45 (hVPS45), which in turn binds to v-SNARE proteins and 
leads to fusion of the EE with target membranes (Naslavsky et al., 2009). Along with 
Rab5 and Rab5 effectors on EE, Rab4 is also localized to the EE (Van Der Sluijs et al., 
1991). Rab4 is responsible for the direct exit of the recycling cargo containing vesicles 
from EE to the PM, known as fast recycling, as well as being able to sort these same 
cargos to the ERC (Sheff, Daro, Hull, & Mellman, 1999; Van Der Sluijs et al., 1991). 
 Upon maturation of the EE to a LE, the exchange of Rab5 with Rab7 is a key 
event (Peralta, Martin, & Edinger, 2010). Rab7 is recruited the EE membrane by 
homotypic fusion and by interacting with vacuole protein sorting (HOPS) subunit 
Vam6p/VPS39 (Caplan, Hartnell, Aguilar, Naslavsky, & Bonifacino, 2001; Wurmser, 
Sato, & Emr, 2000). The VPS39 protein interacts with a protein that binds to GTP-bound 
Rab5, Mon1, and displaces the Rabex-5 GEF protein from the membrane. The Mon1, 
along with its interaction partner, Czi1, can recruit Rab7 to the EE. The Mon1/Czi1 
interaction prevents Rab5 from becoming activated again and also promotes the 
activation of the newly acquired Rab7, thus promoting the maturation of the EE to a LE 
(Nordmann et al., 2010). Similar to Rab5, Rab7 also has effector proteins that are 
recruited to the LE to perform specialized functions. Rab7-interacting lysosomal protein 
(RILP), is recruited to the LE and in turn recruits dynein-dynactin motor proteins that 
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allow for transport of the LE toward the minus end of the microtubules (Cantalupo, 
Alifano, Roberti, Bruni, & Bucci, 2001). The previously mentioned HOPs complex 
remains in contact with Rab7- positive LE and promotes tethering and fusion of the LE 
with target membranes through SNARE proteins. 
 A number of other Rab proteins play a role in regulating various steps in the 
endocytic pathway and include Rab11, Rab21, Rab 22, Rab8, Rab15, Rab35, (B. D. Grant 
& Donaldson, 2009; Grosshans et al., 2006; V. W. Hsu & Prekeris, 2010), and it was 
recently found that Rab10 associates with MICAL-L1 and localizes to TREs; however the 
function of Rab10 on the TRE is still being explored (Etoh & Fukuda, 2019). Not only are 
the Rab proteins present in the endocytic pathway, but the Rab effector proteins as well 
(Grosshans et al., 2006). Some of the Rab effector proteins are also able to interact with 
the aforementioned EHD1 protein (Naslavsky & Caplan, 2011). As previously 
mentioned, Rab4 is a well-known regulator of fast recycling from EE back to the PM, 
and Rab4 alone does not access the ERC. However, if Rab4 and Rab11 are both located 
on the EE, it can lead to the delivery of the cargo to ERC (Sonnichsen, De Renzis, 
Nielsen, Rietdorf, & Zerial, 2000). Rab11 binds to its effector proteins, Rab11 family-
interacting protein 5 (FIP5) and Rab11-FIP2, which in turn recruit important players of 
the slow recycling pathway. These proteins include the kinesin II motor protein, KIF3B 
(Schonteich et al., 2008), myosin Vb (Roland, Kenworthy, Peranen, Caplan, & 
Goldenring, 2007), EHD1, and EHD3 (Naslavsky, Rahajeng, Sharma, Jovic, & Caplan, 
2006). Similar to Rab4 function, Rab35 is able to promote the fast recycling of receptors 
(Allaire et al., 2010; Sato et al., 2008). However, Rab35 and its effector protein, MICAL-
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L1, can localize to TRE and serve as scaffolding proteins to recruit various proteins that 
are critical to TRE homeostasis, such as EHD1 (Giridharan, Cai, Naslavsky, & Caplan, 
2012). Besides these Rab proteins and their effectors, other types of Rab proteins play a 
role in the slow recycling pathway. For example, Rab8 is recruited to TRE by MICAL-L1 
and is involved in the Rab11-Rab8-Myosin Vb complex that recycles cargos back to the 
PM (Huber et al., 1993; Roland et al., 2007). Rab22a is also found on tubules generated 
from the ERC and plays a role in mediating tubule generation and the fusion of 
recycling endosome membranes and the PM (Weigert, Yeung, Li, & Donaldson, 2004). 
Rab22a may also play a role in cargo selection within the slow recycling pathway as it 
preferentially traffics the MHC 1 protein and has little effect on the Tf receptor.  
 While Rab proteins play a major role in endocytic trafficking, there is another 
family of proteins that are also guanine nucleotide-binding proteins termed ADP-
ribosylation factor (Arf) proteins. The Arf proteins regulate organelle dynamics and 
membrane trafficking in a similar manner to that of Rab proteins (Donaldson & Jackson, 
2000). Arf proteins can be divided into different classes with the class 1 (Arf1-3) group of 
Arf proteins mediating the trafficking between the ER-to-Golgi (D'Souza-Schorey & 
Chavrier, 2006). On the other hand, the class III group of Arf proteins (Arf6) stimulates 
endocytosis by promoting the invagination of the PM (Naslavsky et al., 2003). As 
previously mentioned, Arf6 functions more as a lipid and cytoskeleton modifier by the 
activation of PI5K, which in turn enriches the membrane in PIP2. PIP2 enrichment at the 
PM promotes membrane trafficking and actin rearrangement (Czech, 2003; Yin & 
Janmey, 2003). Arf6 is responsible for the internalization of cargos such as MHCI, G 
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protein-coupled receptors, E-cadherin and β1-integrin (Brown, Campbell, & Sanderson, 
2001; Houndolo, Boulay, & Claing, 2005; Naslavsky et al., 2003; Radhakrishna & 
Donaldson, 1997). Arf6 also coordinates with EHD1 to mediate the MHCI-containing 
TRE and the localization of Rab8 and MICAL-L1 to tubular membranes (Caplan et al., 
2002; Rahajeng, Giridharan, Cai, Naslavsky, & Caplan, 2012). 
2.3 v-SNARE and t-SNARE proteins 
 In general, the soluble N-ethylmaleimide-sensitive factor attachment receptor 
(SNARE) proteins mediate fusion events of two membranes by utilizing the SNARE 
motif that resides in each protein (Bennett, 1995; Fasshauer, 2003; Sollner, 1995). The 
SNARE motif consists of a helix-forming structure that has an evolutionarily conserved 
domain of 60-70 amino acids, along with heptad repeats. In order for two endocytic 
membranes to fuse using SNARE proteins, the vesicle membrane SNARE (v-SNARE) 
interacts with the target membrane SNARE (t-SNARE) by association with the SNARE 
motifs found in each protein. This association forms a four-helical bundle that is 
extremely stable and provides the energy to undergo fusion of the vesicle with the target 
membrane (Y. A. Chen & Scheller, 2001; Sutton, Fasshauer, Jahn, & Brunger, 1998). Some 
specific examples of SNARE proteins that are involved in the homotypic fusion of EE is 
syntaxin13, VPS10p tail interactor 1 (vit1a), syntaxin6, and VAMP4 (Brandhorst et al., 
2006; Zwilling et al., 2007). The Rab5 effector, EEA1, plays a major role in recruiting 
SNARE proteins to the EE and if the recruitment of EEA1 is disrupted by PI3K 
inhibition, the activity of EEA1 is impaired, leading to EE that are unable to fuse 
properly (McBride et al., 1999; Simonsen et al., 1999). Like many other complexes, once 
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the fusion of homotypic EE is completed, the complex must be disassembled. The 
disassembly of the SNARE complex is regulated by AAA+ (ATPases Associated with 
diverse cellular Activities) protein N-ethylmaleimide-sensitive factor (NSF) (Hanson & 
Whiteheart, 2005; Mayer, Wickner, & Haas, 1996). The disassembly of the SNARE 
complex is initiated by the binding of 3 NSF attachment proteins (SNAP) with the four-
helical bundle generated from the fusion of the v-SNARE and t-SNARE and uses the 
energy from ATP hydrolysis to break the bundle apart (Sollner, 1995). (Figure 1.4) 
2.4 C-terminal Eps15 homology domain (EHD) protein family 
 The mammalian EHD family is comprised of four proteins, EHD1-4. This family 
of proteins has the ability to homo- and hetero-oligomerize and helps facilitate their 
function in the membrane trafficking pathway (B. D. Grant & Caplan, 2008; Pohl et al., 
2000). The EHD proteins are highly conserved at the amino acid level across many 
species. For example, the EHD family member in C. elegans, RME-1, is 67% identical to 
the human EHD1 amino acid sequence. Furthermore, mammalian EHD1 and EHD3 
share roughly 86% sequence identity, yet are able to perform specific functions (B. D. 
Grant & Caplan, 2008). No matter the species, the EHD proteins share a highly 
conserved domain architecture consisting of an N-terminal G-domain, a central helical 
region and a C-terminal EH domain. The EHD proteins became a highly interesting 
topic of study when EHD1 and RME-1 were found to be crucial in regulating endocytic 










Schematic representation of the steps of vesicle transport. (A) Coat proteins are 
recruited to the cytosolic face of the donor membrane and induce the formation of a 
vesicle. The coat recruits SNAREs and transmembrane receptors bound to their 
cargo. (B) After uncoating, motor protein can be recruited to enable the vesicle to 
travel along microtubules or actin filaments. (c) Once at its destination, the vesicle 
becomes tethered to the acceptor membrane, probably by long coiled-coil proteins or 
multimeric tethering complexes. (D) The SNAREs on the vesicle and acceptor 
membrane form a complex which drives membrane fusion and hence delivery of the 




2.4.1 EHD1  
EHD1 is the best characterized EHD protein and is unique in its localization to 
TREs involved in endocytic recycling (B. D. Grant & Caplan, 2008; Naslavsky & Caplan, 
2011). EHD1 regulates the recycling of many receptors that inter the cell through CME 
and CIE. Cargo that is regulated by EHD1 includes the transferrin receptor (TfR) (Lin, 
Grant, Hirsh, & Maxfield, 2001), major histocompatibility complex class I proteins (MHC 
I) (Caplan et al., 2002), the insulin-regulated GLUT4 transporters (Guilherme, Soriano, 
Furcinitti, & Czech, 2004), the cystic fibrosis transmembrane conductance regulator (Lin 
et al., 2001), AMPA type glutamate receptors (Park, Penick, Edwards, Kauer, & Ehlers, 
2004), MHC class II molecules (Walseng, Bakke, & Roche, 2008), the hyperpolarization- 
activated cyclic nucleotide-gated (HCN) ion channel family members HCN1, HCN2 and 
HCN4 (Hardel, Harmel, Zolles, Fakler, & Klocker, 2008), G-protein-activated inwardly 
rectifying potassium channels (Chung, Qian, Ehlers, Jan, & Jan, 2009), and the calcium-
activated potassium channel KCa2.3 (Gao et al., 2010), and other channels (Guilherme et 
al., 2004). EHD1 and the Rab11 effector protein, Rab11-FIP2, interacts and localizes to 
peripheral EE (Naslavsky et al., 2006). This relationship, along with Rab35, suggests a 
role for EHD1 in the transport of cargo from the EE to the ERC in some capacity (Allaire 
et al., 2010; Sato et al., 2008). It is known that EHD1 is linked with dynein motors via 
collapsing response mediator protein-2 (Crmp2), which in turn regulates the cargo 






Role of EHD proteins in membrane trafficking. The four EHD proteins display 
considerable sequence identity, from ∼68–87%, and have been implicated in 
membrane remodeling (table inset). EHD1, EHD3 and EHD4 have been 
characterized in the regulation of endosomal transport, primarily at the EE, with 
EHD1 additionally involved in the regulation of recycling from the ERC. EHD2, the 
most divergent of the EHD proteins, controls caveolar mobility and may influence 
internalization at the plasma membrane. Used with permission from JCS (Naslavsky 




 Studies have shown that EHD proteins induce lipid tubulation in vitro (Daumke 
et al., 2007), however studies done in cultured cells suggest that the EHD proteins play 
an opposite role and promote fission of lipid tubules. Previous studies of the EH domain 
and the structure of EHD2 provide evidence that they serve as dynamin-like ATPases in 
the fission of endocytic membranes (Cai et al., 2012; Daumke et al., 2007; Jakobsson et al., 
2011; D. W. Lee et al., 2005). In support of EHD1’s function as a fission protein, purified 
EHD1 can be added to an ATP-containing semi-permeable system and induce 
endosomal fission (Cai et al., 2013). Moreover, recent studies have elucidated the 
mechanism by which EHD1 forms oligomers around a tubule and induces fission (Deo 
et al., 2018). Additionally, the nuclear magnetic resonance solution structure of the EHD 
domain of EHD1 (Kieken, Jovic, Naslavsky, Caplan, & Sorgen, 2007) has led to the 
identification of novel interaction partners that contain an asparagine-proline-
phenylalanine (NPF) motifs followed by acidic residues that selectively interact with the 
positively charged EH domain electrostatic surface area (Henry, Corrigan, Dineen, & 
Baleja, 2010). 
 Our lab discovered MICAL-L1 as a direct interaction partner of the EH domain 
of EHD1 (Giridharan et al., 2013; Sharma, Jovic, et al., 2009). The latter binds via the first 
of its two NPF motifs, and MICAL-L1 is required for TRE biogenesis and receptor 
recycling (Giridharan et al., 2013; Sharma, Jovic, et al., 2009). MICAL-L1 interacts with 
many essential regulators of TREs, including Rab8 (Sharma, Jovic, et al., 2009), proteins 
that contain a BAR domain (McMahon & Gallop, 2005; Zimmerberg & Kozlov, 2006), 
including the N-BAR protein Amphiphysin/Bin1 (Pant et al., 2009), and the F-BAR 
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protein Syndapin2 (or PACSIN2) (Braun et al., 2005; Giridharan et al., 2013). MICAL-L1 
and Syndapin2 bind to the PA on the TRE membranes and subsequently recruit EHD1 
to the TRE to facilitate fission, giving rise to newly formed endosomes that contain 
cargos traveling to and from the ERC. 
 In addition to the role that EHD1 plays in the recycling of cargos from the PM, 
EHD1 interacts with VPS26 and VPS35 and in turn can regulate the retrograde transport 
of cargo from EE to the TGN (Gokool et al., 2007). In recent years, the role of EHD1 has 
expanded beyond the realm of recycling and it has been revealed as an important player 
in mitosis and ciliogenesis (Lu et al., 2015; Reinecke, Katafiasz, Naslavsky, & Caplan, 
2015), demonstrating that endocytic regulatory proteins may play a larger role in the cell 
than just controlling endocytic trafficking. This notion that endocytic regulatory proteins 
can play a role in other pathways, such as EHD1 playing a role in mitosis or ciliogenesis, 
has led to us identifying a novel role for EHD1 in mitochondrial fission. 
2.4.2 EHD2  
 EHD2 displays the least amount of homology to EHD1, at only 70% identity. The 
structure of EHD2 has been solved and further supports its role in nucleotide-dependent 
membrane remodeling (Daumke et al., 2007). EHD2 is involved in the regulation of a 
variety of important functions such as sarcolemma repair (Marg, Schoewel), myoblast 
fusion (K. R. Doherty et al., 2008; Posey et al., 2011), and controls Rac1 and the actin 
cytoskeleton (Benjamin et al., 2011; Stoeber et al., 2012). EHD2 plays a very different role 
in regulating endocytic trafficking as compared to the other EHD proteins and is 
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recruited to the PM by preferentially binding to phosphatidylinositol (4,5)-bisphosphate 
(PI(4,5)P2) (Simone et al., 2013) and is able to regulate caveolar mobility at the PM 
(Moren et al., 2012). Previous studies from our lab suggest that the phenylalanine 
residue in the EHD2 NPF motif is crucial for its localization to the PM, while the proline 
plays a key role in EHD2 dimerization and binding (Bahl, Naslavsky, & Caplan, 2015). 
Furthermore, EHD2 is able to bind to the EH-domain-binding protein 1 (EHBP1) 
(Guilherme et al., 2004), which implies that there is functional redundancy with EHD1 
(M. George et al., 2007), as well as a role for EHD2 with the internalization of TfR and 
GLUT4 (Guilherme et al., 2004). 
2.4.3 EHD3 
EHD3 and EHD1 share the highest percentage of amino acid identity at 86% 
(Galperin et al., 2002). However, EHD3 does not seem to play a major role in regulating 
the exit of cargos from the ERC back to the PM. Indeed, upon EHD3-depletion, the cargo 
accumulates in the EE and does not reach the ERC (Naslavsky et al., 2006). Additionally, 
EHD3 is involved in retrograde transport from the EE to the TGN and helps maintain 
the morphology of the Golgi membrane (Naslavsky et al., 2009). EHD3 has the capacity 
to hetero-dimerize with EHD1 and localizes to the tubulovesicular endosomes (Galperin 
et al., 2002). Similar to EHD1, EHD3 binds to Rab effectors, such as Rab11-FIP2, 
Rabenosyn-5, and MICAL-L1 (Naslavsky et al., 2006; Sharma, Jovic, et al., 2009). Studies 
from our lab have shown that upon knockdown of EHD3, fewer MICAL-L1-decorated 
TRE are observed, whereas EHD1-depletion leads to hyper-elongation of TRE. This 
finding was further supported by our semi-intact cell system utilizing purified EHD3, 
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which led to rapid induction of tubules (Cai et al., 2014). Our lab recently elucidated the 
mechanism by which EHD3 supports TRE stabilization, (Bahl et al., 2016) 
2.4.4 EHD4 
EHD4 localizes primarily to EE and may regulate cargo transport from EE to 
both the ERC and the lysosomal degradation pathway (M. George et al., 2007; Sharma et 
al., 2008). Studies performed in neuronal cells have shown that EHD4 functions 
upstream of EHD1 by regulating the internalization of TrkA and TrkB nerve growth 
factor receptors, along with Nogo-A, an inhibitor of axonal growth (Joset, Dodd, 
Halegoua, & Schwab, 2010; Shao et al., 2002; Valdez et al., 2005). However, recent 
studies in our lab have shown that EHD4 and EHD1 can hetero-dimerize and are 
potentially both needed for TRE fission and regulation of cargos back to the PM 
(unpublished data). 
3. REGULATION OF MITOCHONDRIAL FUSION/FISSION 
3.1. Overview 
 Mitochondria are known for their role in generating ATP via oxidative 
phosphorylation but also contribute significantly to many other cellular processes 
including but not limited to regulation of reactive oxygen species (Hamanaka & 
Chandel, 2010), calcium signaling, (Duchen, 2000; Nicholls, 2005), apoptosis (C. Wang & 
Youle, 2009), iron homeostasis (Horowitz & Greenamyre, 2010; Richardson et al., 2010), 
and cellular aging (Srivastava, 2017; Sun, Youle, & Finkel, 2016). The functions that are 
performed by the mitochondria are closely associated with the regulation of their 
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dynamics, which includes continuous rounds of fission and fusion that the mitochondria 
depends upon to remain healthy (Chan, 2012). Disruption of the regulation of 
mitochondrial fission and fusion may result in many diseases, including Alzheimer’s 
disease (Cho et al., 2009) and Parkinson’s disease (PD) (Tang et al., 2015). While there 
have been recent advances in the field of mitochondrial homeostasis, many aspects of 
the mechanisms that control the dynamics of fission and fusion remain undiscovered.  
In order for 2 mitochondria to fuse together, two separate fusion events must 
occur, with the first being fusion of the mitochondrial outer membrane (MOM) and the 
second being the fusion of the mitochondrial inner membrane (MIM). To date, it is 
known that 3 GTPases directly regulate mitochondrial fusion. Mitofusin-1 (Mfn1) and 
Mitofusin-2 (Mfn2) are in charge of fusing the MOM, while the MIM is fused together by 
optic atrophy 1 (OPA1). The fusion of two mitochondria is critical for maintaining 
membrane potential and thus ATP production (H. Chen et al., 2003). Fusion events are 
also critical for the proper transfer of mitochondrial proteins and mitochondria DNA 
(mtDNA) to newly formed mitochondria (Twig & Shirihai, 2011).  
The proteins that are needed for mitochondrial fission are just as crucial as the 
fusion proteins. Mitochondria are constantly balancing the amount of fission and fusion 
to maintain optimal size and shape. Mitochondrial fission is regulated by a long-known 
GTPase fission protein, dynamin-related protein 1 (Drp1) (Smirnova, Griparic, Shurland, 
& van der Bliek, 2001). However, it wasn’t until recently that researchers discovered a 
role for another GTPase, dynamin-2 (J. E. Lee, Westrate, Wu, Page, & Voeltz, 2016). 
37 
 
While the GTPases are thought to provide the energy needed for a mitochondria to 
undergo fission, the process of mitochondrial fission is more complicated and requires 
the use of other organelles, such as the endoplasmic reticulum (ER), which helps initiate 
the mitochondrial fission before the GTPases are present. Mitochondrial fission events 
are critical for remodeling and rearrangement of mitochondria within the cell or the 
need to be transferred to a new cell during mitosis (Pagliuso, Cossart, & Stavru, 2018). 
Since mitochondrial fission is an important cellular event, subtle changes in the rate of 
fission are enough to influence disease states such as Alzheimer’s disease (Castellani et 
al., 2002; Moreira, Cardoso, Santos, & Oliveira, 2006) or cardiomyocyte hypertrophy 
(Ago et al., 2010; Pennanen et al., 2014). 
3.2 Effectors of fusion 
3.2.1 Mitofusin-1 and Mitofusin-2 (Mfn1 and Mfn2) 
Mfn1 and Mfn2 perform similar functions in the fusion of the MOM and can 
even interchange under certain conditions (H. Chen et al., 2003). While Mfn1 and Mfn2 
are interchangeable, mutations in Mfn2 alone can have serious consequences and result 
in disease states such as Charcot-Marie-Tooth Neuropathy type 2A (H. Chen, Chomyn, 
& Chan, 2005; H. Chen et al., 2003). This suggests that it only takes a minor disturbance 
in the balance between fission and fusion to disrupt mitochondrial function and lead to a 
disease state. Mfn1 and Mfn2 are MOM transmembrane GTPases that contain several 
conserved domains such as an amino-terminal GTP-binding domain, 2 coiled-coil 
domains and a carboxyl-terminal with a bipartite transmembrane domain (Chandhok, 
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Lazarou, & Neumann, 2017). While Mfn1 and Mfn2 do play similar roles and have 
structural homology, Mfn2 has an N-terminal Ras-binding domain that is lacking in 
Mfn1, suggesting that Mfn2 might have specificity towards a cellular pathway that Mfn1 
does not have (K. H. Chen et al., 2004). The second coiled-coil domain of Mfn1 or Mfn2 
is responsible for the tethering of the opposing mitochondria through dimerization of 
anti-parallel coiled-coiled domains, forming either homotypic or heterotypic dimers 
(Koshiba et al., 2004). Understanding the precise mechanism of signaling that allows 
Mfn1 or Mfn2 to join two adjacent mitochondria is under active research. (Figure 1.6). 
3.2.2 Optic atrophy protein 1 (OPA1) 
OPA1 is the major protein that is responsible for the fusion of the MIM and is also 
thought to be involved in proper cristae folding as well as potentially playing a role in 
apoptosis (Griparic, van der Wel, Orozco, Peters, & van der Bliek, 2004; Ni, Williams, & 
Ding, 2015). Interestingly, OPA1 requires the presence of Mfn1 but not Mfn2 to be 
functional (Cipolat, Martins de Brito, Dal Zilio, & Scorrano, 2004). The loss of OPA1 
function can lead to dominant atrophy, an inherited disease that culminates in the 
degeneration of the optic nerve, suggesting that OPA1 may be important in 
mitochondrial fusion and homeostasis (H. Chen & Chan, 2005, 2009). For OPA1 to 
become fully functional, it must be transported to the mitochondria and undergo 
proteolytic cleavage into 2 separate isotypes, known as long and short forms (Ishihara, 






Mitochondrial fusion. Mitochondrial fusion via homotypic and heterotypic 
mitofusin interactions mediates OMM fusion, while OPA1 is responsible for IMM 




conditions are nearly equal and must remain that way for fusion of the MIM (Liesa, 
Palacin, & Zorzano, 2009). The long and short isotypes cannot work separately to 
complete MIM fusion but must work in tandem to successfully fuse two mitochondria 
(Song, Chen, Fiket, Alexander, & Chan, 2007) (Figure 1.6).  
3.3 Effectors of fission 
3.3.1 ER/mitochondria contact sites 
Previous studies have shown that the ER and the mitochondria share contact 
sites that are essential for phospholipid synthesis, calcium signaling, and marking 
constriction sites on the mitochondria, indicating where fission needs to occur (de Brito 
& Scorrano, 2010; Friedman et al., 2011). There are several types of connections or 
bridges that can be made between the ER and the mitochondria. For example, a distinct 
structure termed the ER mitochondria encounter structure (ERMES) can be found in 
yeast and is involved in mitochondrial fission, while in mammalian cells, the fusion 
protein, Mfn2, is potentially responsible for tethering the ER and mitochondria together 
(de Brito & Scorrano, 2008; Kornmann et al., 2009). More recent studies have been able to 
identify PDZ domain containing 8 (PDZD8), a homolog of the yeast ERMES protein 
maintenance of mitochondrial morphology protein (MMM1), as playing a crucial role in 
tethering mitochondria to the ER in mammalian neurons (Hirabayashi et al., 2017). It is 
interesting to note that even with mitochondria remaining dynamic under physiological 
conditions, the ER contact sites seem to be very stable, suggesting their presence is 
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constantly needed for mitochondrial homeostasis (Friedman, Webster, Mastronarde, 
Verhey, & Voeltz, 2010). 
 It is thought that the ER plays a role in the initial constriction of the 
mitochondria, to promote fission (Friedman et al., 2011; Korobova, Ramabhadran, & 
Higgs, 2013). Indeed, it has been demonstrated that the ER-localized inverted formin 2 
protein is able to induce actin polymerization between the ER and mitochondria, which 
is the driver for initial mitochondrial fission (Korobova et al., 2013). The initial 
constriction done by the ER is critical to facilitate a proper fission event as Drp1 
oligomers are unable to wrap around a non-constricted mitochondria. Mitochondria 
typically have a diameter around 200 nm or more and based on their size, Drp1 
oligomers can form around structures that have a maximal diameter of 110 to 130 nm 
(Friedman et al., 2011). Consistent with this data, ER constriction sites have been known 
to constrict the mitochondria down to around 140 nm in diameter, suggesting that the 
ER must first constrict the mitochondria to allow Drp1 oligomers to further constrict 
(Friedman et al., 2011) (Figure 1.7). 
3.3.2 Dynamin-related protein 1 (Drp1) 
 Under normal conditions, Drp1 is mainly a cytosolic protein that is recruited to 
the mitochondria upon initial constriction by the ER. Drp1 is part of the dynamin family 
of GTPase proteins but unlike its isoform, dynamin-2, Drp1 lacks a lipid-binding 
pleckstrin homology domain; therefore it is unable to bind directly to the mitochondrial 
membrane (Mears et al., 2011; Pagliuso et al., 2018). To make up for the lack of binding, 
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Drp1 must bind to receptors that are found on the mitochondrial membrane. In 
mammalian cells, many Drp1 receptors located on the MOM have been identified, such 
as mitochondrial fission 1 protein (Fis1), mitochondrial fission factor (Mff), or 
mitochondrial dynamics protein 49 and 51 (MiD49/MiD51) (Loson, Song, Chen, & Chan, 
2013; Otera et al., 2010; Palmer et al., 2013; Palmer et al., 2011; Zhao et al., 2011). While 
all of the receptors can recruit and bind Drp1 to the mitochondrial membrane, studies 
suggest that Mff is the most prominent receptor for mitochondrial fission (Loson et al., 
2013). Once Drp1 is recruited to the MOM, oligomers form around the ER and Drp1 uses 
GTP hydrolysis to further constrict the mitochondria. However, it is important to note 
that Drp1 is unable to complete the fission process and therefore needs an additional 
fission factor (Frohlich et al., 2013). (Figure 1.7). 
3.3.3 Dynamin-2 (Dyn2) 
 As previously mentioned, the role of Dyn2 has been well-established in the 
fission of clathrin-coated vesicles at the plasma membrane during endocytosis 
(Gonzalez-Jamett et al., 2013). Similar to Drp1, Dyn2 is able to form oligomers around a 
membrane and use its GTPase function to complete a fission event (Ferguson & De 
Camilli, 2012). Until recently, the model for mitochondrial fission proposed that after the 
initial constriction of the mitochondria by the ER, Drp1 was able to further constrict the 
mitochondria until a single mitochondria splits into two separate structures. However, 
new evidence now supports the model that Dyn2 not only acts at the plasma membrane 





Mitochondrial fission. Constriction of the mitochondrial membrane is first initiated 
by the ER at ER/mitochondria contact sites. After constriction by the ER, the 
mitochondrial membrane is “marked” for fission, thus resulting in Drp1 recruitment 
by Drp1 receptors. Drp1 then forms oligomers around the constriction site and 
further constricts the membrane through GTPase activity, leading to Dyn2/Dnm2 
recruitment, additional GTP hydrolysis, and completion of the process of fission 




constriction by the ER and Drp1 (J. E. Lee et al., 2016). It has been shown that Drp1 and 
Dyn2 must both be present for mitochondrial fission to occur. Loss of either protein 
leads to elongated mitochondria due to a lack of fission (J. E. Lee et al., 2016). The 
studies performed by Lee et al. highlight the growing appreciation for the role of 
endocytic regulatory proteins in mitochondrial homeostasis. (Figure 1.7) 
3.4 Other modes of regulating mitochondrial fusion and fission 
 Traditionally, it is thought that mitochondrial homeostasis is regulated by the 
GTPases, Mfn1, Mfn2, OPA1, Drp1 and its MOM receptors, and more recently, Dyn2. 
However, recent mitochondrial homeostasis research has demonstrated that the 
regulation of mitochondria is far more complex than previously thought. Studies are 
starting to show how important the upstream events that involve the trafficking and 
regulation of the mitochondria-associated proteins, thus providing additional 
mechanisms of indirect mitochondrial fission and fusion. 
 One key protein that indirectly regulates mitochondrial homeostasis through the 
trafficking of mitochondrial-associate fusion or fission proteins is vacuolar protein 
sorting 35 (VPS35) (Tang et al., 2015; W. Wang, Ma, Zhou, Liu, & Zhu, 2017; W. Wang et 
al., 2016). VPS35 is a subunit of a larger complex termed retromer cargo selective 
complex (CSC). The retromer CSC is comprised of 3 vacuolar protein sorting proteins, 
VPS26, VPS29, and VPS35, and associates with sorting nexin proteins (SNX) (Seaman, 
2004). The original function described for the retromer CSC was retrieval of the 
mannose-6 phosphate receptor (M6PR) from peripheral endosomes back to the trans-
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Golgi network (TGN) (Arighi, Hartnell, Aguilar, Haft, & Bonifacino, 2004). Later on, 
other cargo was found to be regulated by the retromer, including the iron transporter 
DMT1-11/Slc11a2 (Tabuchi, Yanatori, Kawai, & Kishi, 2010), the Wnt transport protein 
Wntless/MIG-14 (Eaton, 2008), and others. Exciting new studies have implicated a role 
for VPS35 in mitochondrial fusion and fission as they relate to PD (Tang et al., 2015; W. 
Wang et al., 2017; W. Wang et al., 2016). While VPS35 has been associated with 
mitochondrial homeostasis and PD, the mechanisms by which VPS35 regulates 
mitochondrial morphology remains controversial and unclear.  
3.4.1. Indirect role of VPS35 in mitochondrial fusion 
 The proteins associated with regulating the fusion of mitochondria, Mfn1, Mfn2, 
and OPA1, are regulated by post-translational modifications, with one key type of 
modification being ubiquitination. The ubiquitination of Mfn2 targets the fusion protein 
for degradation by the proteasome, thus limiting the amount of fusion that can take 
place. Recent studies have demonstrated a role for VPS35 in regulating the 
ubiquitination of Mfn2, most likely by trafficking of the E3 ubiquitin ligase, MUL1, 
which is responsible for ubiquitinating Mfn2 on the mitochondria membrane (Tang et 
al., 2015). Tang et al showed that VPS35-depletion induces a PD-like condition that 
causes fragmented mitochondria and cell death in mouse dopamine neurons (Tang et 
al., 2015). Under these experimental conditions, VPS35 interacts with MUL1 and 
sequesters it in the cytoplasm but under VPS35-depletion conditions, the MUL1 is free to 
traffic to the mitochondria where it ubiquitinates Mfn2 and induces the degradation of 
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Mfn2, leading to reduced mitochondrial fusion and fragmented mitochondria. (Top 
portion of Figure 1.8) 
3.4.2. Indirect role of VPS35 in mitochondrial fission 
 While the previously mentioned study suggests a role for VPS35 in the 
regulation of mitochondrial fusion, a recent study provides experimental evidence that 
supports a role for VPS35 in the regulation of mitochondrial homeostasis. Wang et al. 
demonstrated that VPS35 binds to complexes of inactive mitochondrial fission proteins, 
Drp1, on the mitochondrial membrane. It is proposed that upon binding of VPS35 and 
inactive Drp1 on the mitochondrial membrane, mitochondrial-derived vesicles (MDVs) 
are generated and therefore remove the inactive Drp1 for transport to the lysosome for 
degradation (W. Wang et al., 2017; W. Wang et al., 2016). As a result, this frees Drp1 
receptors at mitochondrial constriction sites to recruit and/or activate Drp1 and promote 
mitochondrial fission (W. Wang et al., 2017; W. Wang et al., 2016). The MDVs generated 
in this model consist of structures with diameters of 70 to 150 nm (Cadete et al., 2016) 
and are considered to be important for quality control mechanisms that deliver 
mitochondria-related proteins and membranes to the late endosomes or multivesicular 
bodies (Soubannier, McLelland, et al., 2012). While the exact mechanism of how the 
cargo for the MDVs is selected at the mitochondria is unknown, studies have shown that 
both MIM and MOM membranes can be used to generate MDV and contain both 
membrane bound and mitochondrial matrix proteins (McLelland, Soubannier, Chen, 
McBride, & Fon, 2014; Neuspiel et al., 2008; Soubannier, McLelland, et al., 2012; 
Soubannier, Rippstein, Kaufman, Shoubridge, & McBride, 2012). It is important to note 
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that a mutated form of VPS35 that is commonly found in PD, VPS35D620N, causes 
extensive mitochondrial fragmentation and loss of function, providing additional 
evidence that VPS35 plays a critical part in PD related dysfunction. (Bottom portion of 
Figure 1.8). 
4. REGULATION OF MITOCHONDRIA INDUCED APOPTOSIS 
4.1 Overview 
 Apoptosis is an essential cellular event that is required for normal development 
and maintenance of whole tissue homeostasis, protection from genomic miscues, and to 
control humoral immune responses (Slomp & Peperzak, 2018). During the process of 
apoptosis, a cell will begin to shrink, fragment its DNA, and eventually break up into 
smaller apoptotic bodies that can easily be cleared by phagocytes (Fadeel & Orrenius, 
2005). The process of apoptosis results in activation of cysteine proteases termed 
caspases that cleave cellular proteins that are critical for survival. These caspases are 
activated through either an extrinsic apoptosis pathway, which becomes active when the 
death receptor, located on the surface of the target cell, becomes engaged. Caspases can 
also be activated by the intrinsic pathway that is initiated by internal cellular stresses. 
Apoptosis is a highly regulated process, making it impossible to expand on every aspect 
of both the extrinsic and intrinsic pathways. Due to this, I will focus primarily on the 
intrinsic pathway of apoptosis, in particular, the regulation of the intrinsic pathway by 
the B-cell lymphoma 2 (Bcl-2) family of proteins. For more detailed information on the 





Potential roles of VPS35 in mitochondrial fission/fusion. Model representing the 
role of VPS35 (pink) in mitochondrial fission (bottom left) or mitochondrial fusion 
(top right). For fission, VPS35 removes inactive Drp1 (red) and traffics it to the 
lysosome for degradation, to allow active Drp1 (green) to further constrict the OMM. 
For fusion, VPS35 regulates MUL1 (orange) localization to the OMM, where it binds to 
Mfn2 (red) and induces its polyubiquitination (yellow) to target it for proteasomal 
degradation. Used with permission from Traffic (Farmer et al., 2018). 
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4.2 Bcl-2 protein family regulation 
 The Bcl-2 family of proteins is a key group of regulators that controls apoptosis 
by regulating the mitochondrial outer membrane permeabilization MOMP. Once 
MOMP occurs, cytochrome c is released and activates the caspases that carry out the rest 
of the apoptotic process. The Bcl-2 family can be divided into 3 main groups depending 
on the function that they serve in either preventing or promoting mitochondria induced 
apoptosis (1) anti-apoptotic proteins (Bcl-2, Bcl-xL, Bcl-W, Mcl-1, Bfl-1/A1), (2) pro-
apoptotic pore-formers (Bax, Bak) and (3) pro-apoptotic BH3-only proteins (BAD, BID, 
BIK, BIM, BMF, HRK, NOXA, PUMA, etc.) (Kale, Osterlund, & Andrews, 2018). All of 
the Bcl-2 family members contain a BH3 domain, which is one of the four BH domains 
that help facilitate the interactions between family members (Lomonosova & 
Chinnadurai, 2008). Members of the anti-apoptotic and pro-apoptotic groups contain all 
4 of the BH domains and therefor have a highly conserved structure that forms a 
hydrophobic BH3 domain-binding groove (Shamas-Din, Brahmbhatt, Leber, & 
Andrews, 2011). In addition to the BH domains, most of the Bcl-2 family members have 
a transmembrane domain (TD) that allows them to localize to various membranes, such 
as the mitochondria or ER. The Bcl-2 family members who do not have the TD interact 
with other proteins on the membranes. The ability of different Bcl-2 proteins to interact 
with each other is critical for regulation of MOMPs. When the interactions favor the pore 
formation of Bax/Bak on the MOM, cytochrome c is released from the mitochondria and 
the intrinsic pathway is activated (Wei et al., 2001). BH3-only proteins play a role as cell 
death initiators whose activity is transcriptionally or post-translationally regulated 
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depending on the upstream cell signaling (Czabotar, Lessene, Strasser, & Adams, 2014; 
Danial & Korsmeyer, 2004; Youle & Strasser, 2008). (Figure 1.9) 
 There are various competing models for how the interactions between Bcl-2 
family members interact to either prevent or promote apoptosis. However, in all models, 
the BH3 domain is a necessary component for the primary apoptotic function of Bcl-2 
family members and mediates the interactions between them. For example, the BH3 
domain of the BH3-only activator proteins can bind to the BH3 domain-binding groove 
of the Bax or Bak and activate them to induce mitochondria pore formation and 
apoptosis (Czabotar et al., 2013; Moldoveanu et al., 2013). Upon binding of the BH3-only 
activator to Bax or Bak, a series of conformational changes occurs that allows for the Bax 
or Bak to be homo-oligomerized and form the pore in the MOM (Kale et al., 2018). On 
the other hand, the BH3 domain-binding groove of the anti-apoptotic proteins can bind 
to the BH3 domains of Bax and Bak, along with the BH3-only activator proteins and thus 
inhibit their function by sequestering the pro-apoptotic proteins and thus preventing 
MOM pore formation (Ku, Liang, Jung, & Oh, 2011; Liu et al., 2010). The BH3-only 
sensitizer proteins can bind also bind to the BH3 domain-binding groove of the anti-
apoptotic proteins and inhibit them from sequestering the pro-apoptotic proteins, 
resulting in an increase in the pore formation in the MOM (Petros et al., 2000). For the 
most part these interactions occur at or in the MOM and the lipid composition of the 
membrane plays a key role in facilitating structural changes of the Bcl-2 family of 
proteins and the structure of the protein dictates the binding affinity between family 
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members, thus controlling whether pores will be formed or not (Chi, Kale, Leber, & 
Andrews, 2014; Shamas-Din et al., 2013). (Figure 1.9) 
5. SUMMARY AND CONCLUSIONS 
 Endocytic trafficking is a highly regulated and important process for overall 
cellular health. There have been major advances in understanding how the proteins that 
regulate this pathway interact, sort, and traffic internalized cargo from the PM over the 
last two decades. Along with determining the mechanisms by which they regulate 
trafficking, there is a growing body of work showing a relationship between endocytic 
regulatory proteins and other organelles, such as centrosomes, cilia, and mitochondria. 
For example, the role of the GTPase Dyn2 in both endocytic fission at the PM and in 
mitochondrial fission has been highlighted recently as well as the novel role for the 
retromer complex in regulating the trafficking of Drp1. The newly discovered function 
of the retromer has solidified the links between endocytic pathways and mitochondria. 
However, it remains unknown whether other proteins that interact with the retromer 
also play a role in the regulation of mitochondrial fusion or fission. Chapter II will 
highlight a novel role for the retromer interaction partners, EHD1 and Rabankyrin-5, in 
indirectly regulating mitochondrial fission through control of the retromer localization.  
 Mitochondria play many roles within the cell to help maintain overall 
homeostasis, such as reactive oxygen regulation, calcium signaling, apoptosis, iron 





BCL-2 family interactions and regulation of BAX/BAK oligomerization. BAX/BAK 
activation is directly triggered by activator BH3-only proteins (BIM, BID and PUMA) 
and is inhibited by anti-apoptotic BCL-2 family members. Sensitizer BH3-only 
proteins do not activate BAX and BAK directly, but lower the threshold for apoptosis 
by binding anti-apoptotic members and releasing activators to trigger BAX and BAK 
oligomerization. Anti-apoptotic BCL-2 proteins inhibit activator BH3-only proteins 
and BAX/BAK oligomerization. Used with permission from Trends in Endocrinology 




that endocytic regulatory proteins play a key role in regulating the fusion and fission of 
mitochondria, it raises the question whether they also play a role in other mitochondrial 
functions. All of these functions are extremely important for cellular health but the role 
that mitochondria play in apoptosis might be the most important. Apoptosis induced by 
permeabilization of the mitochondrial membrane is regulated by the Bcl-2 family of 
proteins. Some of these proteins can be found on the mitochondrial membrane, while 
others, such as Bax or Bcl-xL, must traffic to the mitochondria to either form pores or 
prevent pore formation,. Studies have shown that Bax most likely undergoes simple 
diffusion to reach the mitochondrial membrane. However, to date there is no available 
data to explain how Bcl-xL traffics to the mitochondria to prevent pore formation. 
Although Bcl-xL may undergo simple diffusion, given how highly regulated apoptosis 
is, it is logical to think there is something regulating this translocation from the 
cytoplasm to the mitochondria. Chapter III will describe, for the first time, a relationship 
between endocytic regulatory proteins and Bcl-xL. In this chapter I propose a model for 
how the retromer is able to regulate the translocation of Bcl-xL to the mitochondrial 














ROLE OF ENDOCYTIC REGULATORY PROTEINS IN MITOCHONDRIAL 
HOMEOSTASIS 
 
With permission from Journal of Cell Science, parts of this chapter were derived from: 
(Farmer et al., 2017) 
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 Mitochondria play crucial roles in producing cellular energy, regulating reactive 
oxygen species (ROS), and controlling apoptosis. Mitochondrial function is regulated by 
constant fusion and fission but the mechanisms that maintain mitochondrial 
homeostasis remain incompletely understood. Recent studies implicate Dyn2 and Drp1 
as two GTPases that are required for regulating mitochondrial fission. In Chapter II, we 
demonstrate that the ATPase and endocytic protein, EHD1, is a novel regulator of 
mitochondrial fission. Depletion of EHD1 results in static and elongated networks of 
mitochondria, similar to that observed upon Dyn2- or Drp1-depletion. However, 
depletion of Dyn2 or Drp1 interferes with the susceptibility of cells to staurosporine-
induced mitochondrial fragmentation, whereas EHD1-depleted cells remain sensitive to 
staurosporine (STS), suggesting that EHD1 functions through a different mechanism 
than the two GTPases. Recent studies have demonstrated that VPS35 and the retromer 
complex influence mitochondrial morphology by one of two mechanisms: 1) Decreased 
fusion by Mul1-mediated ubiquitination and degradation of fusion protein Mfn2, or 2) 
Increased fission by removing inactive Drp1 from the mitochondrial membrane. Herein, 
we provide evidence that EHD1 and its interaction partner, Rabankyrin-5, interact with 
the retromer complex to influence mitochondrial dynamics, likely by inducing VPS35 to 
remove inactive Drp1 from the mitochondrial membrane. Chapter II sheds light on 
mitochondrial homeostasis, expanding on novel concepts pertaining to endocytic 




Mitochondria play an essential role in the overall homeostasis of a cell. Among 
their many functions are the regulation of ATP levels via oxidative phosphorylation, 
Ca2+ signaling (Duchen, 2000; Nicholls, 2005), apoptosis (C. Wang & Youle, 2009), and 
ROS generation and sequestration (Hamanaka & Chandel, 2010). The function of the 
mitochondria is closely controlled by their dynamics, and they are continually 
undergoing rounds of fusion and fission, a process required for mitochondrial health 
and homeostasis (Chan, 2012). Indeed, small disruptions in the dynamics of 
mitochondria can result in a wide variety of diseases, such as Alzheimer’s disease (Cho 
et al., 2009) and PD (Tang et al., 2015). The mechanisms by which mitochondrial 
dynamics influence these neurological disorders remain unclear. However, fusion and 
fission control mitochondrial size and shape, the total number of mitochondria, and 
many mitochondrial functions such as respiration and cell survival (Chan, 2012; Flippo 
& Strack, 2017). Despite the significance of mitochondrial dynamics and the growing 
number of molecules involved in these events, many of the mechanisms regulating 
mitochondrial dynamics remain unknown. 
 For mitochondria to undergo fusion, there need to be two distinct fusion events, 
between both the outer membranes and inner membranes of apposing mitochondria. 
Three mammalian GTPases have been implicated in regulating mitochondrial fusion: the 
mitofusins Mfn1 and Mfn2 control fusion of the MOM (Rojo, Legros, Chateau, & 
Lombes, 2002; Santel & Fuller, 2001) and OPA1 mediates fusion of the MIM (Alexander 
et al., 2000; Delettre et al., 2000). The dynamin-related GTPase Drp1 has been identified 
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as a key protein required for mitochondrial fission (Bleazard et al., 1999; Labrousse, 
Zappaterra, Rube, & van der Bliek, 1999). Mitochondrial membrane receptors recruit 
Drp1 to the MOM, where it functions in constriction, and the absence of Drp1 from the 
cell leads to elongated mitochondrial networks. In addition to Drp1, a recent study 
demonstrated that Dyn2 coordinates with Drp1 to sequentially mediate the final step of 
mitochondrial fission (J. E. Lee et al., 2016).  
 While identification of proteins that play a direct role in mitochondrial 
homeostasis and the elucidation of their mechanisms of action has expanded rapidly in 
recent years, less is known about the indirect regulation of mitochondrial fusion and 
fission. One new enticing area of research relates to recent studies pointing to a novel 
role for endocytic regulatory proteins in controlling mitochondrial fusion and fission. 
For example, VPS35, a component of the retromer cargo selection complex that initially 
was described as being responsible for regulating the trafficking of cargos from 
endosomes to the Golgi (Arighi et al., 2004), is a key regulator of mitochondrial 
dynamics and one of only a handful of proteins that cause familial PD (Kumar et al., 
2012; Vilarino-Guell et al., 2011; Zimprich et al., 2011). Indeed, suppression of VPS35 in 
hippocampal neurons results in degeneration, abnormal dendritic spines, and swollen 
axons (C. L. Wang et al., 2012), and overall VPS35 expression is decreased in PD patients 
(MacLeod et al., 2013). 
 The mechanisms by which VPS35 and the retromer control mitochondrial 
homeostasis are not well understood. A recent study has shown that a reduction in the 
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protein level of VPS35 in mouse dopamine neurons induces a PD-like phenotype that 
includes neuronal death, α-synuclein deposition and fragmented mitochondria (Tang et 
al., 2015). In the same study, it was shown that VPS35 depletion or mutation led to 
upregulation of Mul1, an ubiquitin ligase that ubiquitinates Mfn2 and inducing the 
degradation of Mfn2 through the proteasome, and may result in more fission than 
fusion, and thus fragmented mitochondria (Tang et al., 2015). On the other hand, a 
second study provides support for a model that suggests VPS35 binds to Drp1 on the 
mitochondrial membrane and facilitates the removal of inactive Drp1 and transports it 
to the lysosome for degradation, allowing active Drp1 to bind to free receptors on the 
mitochondria to promote constriction and eventually fission (W. Wang et al., 2017; W. 
Wang et al., 2016).  
 In Chapter II, we demonstrate that the endocytic fission protein and ATPase, 
EHD1, is a novel player in regulating mitochondrial dynamics and homeostasis. The 
depletion of EHD1 from cultured cells results in an elongated network of mitochondria 
that becomes highly static compared to normal mitochondria. While EHD1 has 
considerable homology to the dynamin family members Drp1 and Dyn2, EHD1 
knockdown is unable to prevent STS-induced mitochondrial fragmentation, unlike the 
knockdown of Drp1 and Dyn2. This suggests that EHD1 does not play a role alongside 
Drp1 and Dyn2 and more likely functions in a regulatory capacity. Previous work in the 
lab has shown that EHD1 and its binding partner Rabankyrin-5 both interact with the 
retromer complex, and we now hypothesize that EHD1 regulates mitochondrial fission 
through its control of VPS35 localization within the cell. My findings support a 
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mechanism by which EHD1 and Rabankyrin-5 interact with the retromer and influence 
mitochondrial homeostasis by controlling VPS35-mediated removal of inactive Drp1 
from the mitochondrial membrane. 
8. MATERIALS AND METHODS 
8.1 Reagents and antibodies 
 Mitotracker Red was purchased from Thermo Fisher Scientific (M7512). STS was 
purchased from Sigma-Aldrich (S5921). Antibodies against the following proteins were 
used:  EHD1 (ab109311, 1:1000 dilution for immunoblotting), Vps26 (ab23892, 1:500 
dilution for immunoblotting), VPS35 (ab97545, 1:500 dilution for immunoblotting), Mfn2 
(ab56889, 1:500 dilution for immunoblotting) and actin (ab14128, 1:4000 dilution for 
immunoblotting) from Abcam; Tom20 (sc-11415, Santa Cruz Biotechnology, 1:1000 
dilution for immunofluorescence); Mul1 (GTX112673, GeneTex, 1:500 dilution for 
immunoblotting); GST conjugated to horseradish peroxidase (HRP) (NA935, Amersham, 
1:5000 dilution for immunoblotting); MICAL-L1 (H00085377-B01P, Abnova, 1:500 
dilution for immunoblotting); Rabankyrin-5 (PA5-24640, Thermo Scientific, 1:200 
dilution for immunoblotting); Drp1 (8570s, Cell Signaling, 1:500 dilution for 
immunoblotting); GM130 (610822, BD Biosciences, 1:500 dilution for immunoblotting); 
donkey anti-mouse IgG light chain conjugated to HRP (715-035-151, 1:10,000 dilution for 
immunoblotting), mouse anti-rabbit IgG light chain conjugated to HRP (211-032-171, 
1:10,000 dilution for immunoblotting), from Jackson; and donkey anti-mouse-IgG 
conjugated to Alexa Fluor 488 (A21202, 1:700 dilution for immunofluorescence), donkey 
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anti-mouse-IgG conjugated to Alexa Fluor 568 (21043, 1:700 dilution for 
immunofluorescence), goat anti-rabbit-IgG Alexa Fluor 488 (A11034, 1:700 dilution for 
immunofluorescence), and goat anti-rabbit-IgG conjugated to Alexa Fluor 568 (A11036, 
1:700 dilution for immunofluorescence) from Molecular Probes. 
8.2 Cell Culture 
 The HeLa cervical cancer cell line was purchased from American type Culture 
Collection (ATCC) and grown in DMEM with high glucose containing 10% fetal bovine 
serum (FBS), 1x penicillin-streptomycin (Invitrogen, 10378016), and 2mM glutamine. The 
immortalized retinal pigment epithelium (RPE) cell line was obtained from ATCC and 
grown in DMEM/F12 containing 10% FBS, 1× penicillin-streptomycin and 2 mM 
glutamine. Cell lines were routinely tested for mycoplasma contamination.   
8.3 siRNA transfection and rescue experiments 
 Custom EHD1 siRNA oligonucleotides (described in (Sharma, Giridharan, 
Rahajeng, Naslavsky, & Caplan, 2009)), and On-Target Rabankyrin-5 siRNA 
oligonucleotides were purchased from Dharmacon. RPE cells were transfected using 
Liptofectamine RNAiMax (Invitrogen) with 40nM oligonucleotide. The efficiency of the 
knockdown was measured by immunoblotting or immunofluorescence at 72 h post 
transfection for each experiment. For rescue experiments, RPE cells were simultaneously 
treated for EHD1 siRNA and transfected using Fugene 6 (Roche) with a GFP-myc-EHD1 
construct engineered with silent mutations making it resistant to the siRNA 
oligonucleotides.   
61 
 
8.4 Recombinant gene expression and protein purification 
 The recombinant DNA constructs (GST-EHD1 and GST-EH1) were expressed in 
E. coli Rosetta (R2) cell strain and purified by affinity chromatography. Briefly, a freshly 
transformed colony of E. coli was inoculated in 50 ml of Luria-Bertani (LB) broth (with 
100 μg/ml of ampicillin) and cultured overnight at 37°C with continuous shaking 
(primary culture). Next, the primary culture was inoculated in 1000 ml of fresh LB broth 
in a 1:100 dilution and incubated at 37°C with continuous shaking until the OD was 
within 0.4-0.6 at 600 nm. The culture was then induced with 1 mM IPTG overnight at 
18°C. The cells were then centrifuged at 2100 x g for 15 min at 4°C. The bacterial pellet 
obtained was re-suspended in ice-cold lysis buffer (1 x PBS, pH 7.4) containing 1 
tablet/10 ml protease inhibitor cocktail (Roche). Sample lysis was performed by six 
cycles of sonication on ice (2 min bursts/2 min cooling/200-200 watts in a Branson 
Sonicator, USA). The lysate was centrifuged at 18000 x g for 30 min at 4°C, which 
allowed separation of clear supernatant and cellular debris. The supernatant was then 
mixed and allowed to bind with glutathione sepharose resin for 4 h at 4°C. The beads 
were then washed two times with 2 x PBS, followed by one time with 1 x PBS. The GST-
tagged proteins then underwent elution for 4 h at 4°C in elution buffer containing 300 
mM Imidazole, 50 mM Tris and 200 mM NaCl, pH 8.0, and 30 mM glutathione (reduced) 
in 50mM Tris-HCl, pH 8.0 followed by centrifugation at 2100 x g for 5 min at 4°C. The 
purified proteins were then dialyzed against dialysis buffer (50 mM Tris pH 8.0, 200 mM 
NaCl, and 100 mM PMSF) overnight at 4°C.  
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8.5 Co-immunoprecipitation and GST pulldown 
 HeLa cells were grown in 100mm dishes until confluent. Cells were lysed using 
buffer containing 50 mM Tris, pH 7.4, 100 mM NaCl, 0.5% Triton X-100, and 1x protease 
cocktail inhibitor (Millipore) (lysis buffer) on ice for 30 min. Lysates were incubated with 
either anti-Mul1 at 4°C overnight. Protein G beads (GE Healthcare) were added to the 
lysate-antibody mix at 4°C for 4 h. Samples were then washed 3 times with the same 
buffer used to lyse the cells. Proteins were eluted from the protein G beads by boiling in 
the presence of 4x loading buffer (250 mM Tris, pH 6.8, 8% SDS, 40% glycerol, 5% β-
mercaptoethanol, 0.2% bromophenol blue) for 10 min. Eluted proteins were then 
identified by immunoblotting (described below).  
 For GST pulldowns, 50 μg of purified GST fusion proteins, EHD1 and EH1, were 
incubated with GST beads in lysis buffer and incubated at 4°C for 4 h. The GST beads 
were then washed three times with the lysis buffer. The GST beads were then added to 
bovine brain cytosol at 4°C overnight. Samples were then washed three times with lysis 
buffer. Proteins were eluted from the GST beads by boiling in the presence of 4x loading 
buffer (250 mM Tris, pH 6.8, 8% SDS, 40% glycerol, 5% β-mercaptoethanol, 0.2% 
bromophenol blue) for 10 min. Eluted proteins were then identified by immunoblotting 
(described below). 
8.6 Immunoblotting 
 Cells, HeLa or RPE, were washed twice in ice-cold phosphate-buffered saline 
(PBS) and then scraped off plates with a rubber policeman into ice-cold lysis buffer (50 
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mM Tris-HCl pH 7.4, 100 mM NaCl, 0.5% Triton X-100 and 1x protease cocktail 
inhibitor). Protein levels of post-nuclear lysates were quantified by using the Bradford 
assay for equal protein level loading. For immunoblotting, 20–30 μg of protein per lysate 
were separated by 10% SDS-PAGE. Proteins within the gel were transferred onto 
nitrocellulose membranes and blocked for 30 min at room temperature in PBS with 0.3% 
Tween 20 (PBST) and 5% non-fat dry milk. The membranes were then incubated with 
the appropriate primary antibodies diluted in PBST. Membranes were then washed in 
PBST three times for 5 min and then incubated with the appropriate secondary antibody 
diluted in PBST for 30 min.   
8.7 Quantification of immunoblots 
The adjusted relative density of the immunoblots was measured in ImageJ 
according to the following protocol: 
http://www1.med.umn.edu/starrlab_deleteme/prod/groups/med/@pub/@med/@starrlab/
documents/content/med_content_370494.html. 
8.8 Quantification of mitochondrial parameters 
The average size, perimeter, and circularity of mitochondria were measured in 
ImageJ, using a plugin called Mito Morphology Macro 
(http://imagejdocu.tudor.lu/doku.php?id=plugin:morphology:mitochondrial_morpholog
y_macro_plug-in:start). Images of Tom20-stained cells were imported into ImageJ where 




8.9 Quantification of VPS35 subcellular distribution 
The distribution of VPS35-positive vesicles was assessed using ImageJ. Multi-
channel images were split into individual channels. An area was drawn around the 
Golgi region, marked with a Golgi marker GM130, using the ‘free hand’ tool. The region 
of interest was then superimposed on the image of the VPS35 immunostaining and the 
mean VPS35 fluorescence intensity of that region was measured and calculated. 
8.10 Immunofluorescence 
RPE cells were treated as described in the chapter and then fixed in 4% 
paraformaldehyde in PBS for 10 min at room temperature. Cells were then rinsed three 
times with PBS and then incubated with the appropriate primary antibody diluted in 
PBS containing 0.5% BSA and 0.2% saponin (staining buffer) for 1 h at room 
temperature. The cells were then washed three time and incubated with the appropriate 
secondary antibody diluted in staining buffer for 30 min at room temperature. Upon 
completion, the cells were washed three times with PBS and mounted on a microscope 
slide with Fluoromount. 
 Using a Zeiss LSM800 confocal microscope with a 63×1.4 NA oil objective, z-
stack confocal images were collected. The series of images from a z-stack was then 
processed to yield a maximal projection image using the Zeiss Zen software. For 




8.11 Live imaging 
RPE cells were plated on 35mm glass-bottom dishes and transfected with the 
appropriate siRNA treatment. At 72 h post transfection, the cells were treated with 25 
nM Mitotracker Red for 15 min in Opti-mem media lacking antibiotics. The cells were 
then washed three times with DMEM/F12 containing no Phenol Red. After the last wash, 
DMEM/F12 with no Phenol Red was added to the dish, along with 10% FBS. 
 Using the system described above, a four slice z-stack image was taken every 15 s 
for 5 min for each treatment. Each z-stack was then converted into a maximal projection 
image as described above and quantification was performed.  
8.12 STS assay 
 RPE cells were treated with 1 μM STS (Sigma Aldrich) for the last 1 h of a 72 h 
siRNA transfection. The cells then underwent processing for immunofluorescence as 
described above. 
8.13 Statistics 
 Data from ImageJ was imported in Microsoft Excel where means and standard 
deviations were calculated from the data obtained from three independent experiments 
with at least 10 images taken per treatment. Statistical significance was calculated using 




9.1 EHD1 is a regulator of mitochondrial homeostasis 
 To answer the question whether EHD1 plays a role in mitochondrial fission and 
homeostasis, we depleted EHD1 from retinal pigment epithelial (RPE) cells using siRNA 
and knocked down approximately 90% of the total EHD1 within the cells (Figure 2.1E). 
To compare mitochondrial morphology in mock-treated and EHD1-depleted cells, we 
immunostained RPE cells with Tom20, a mitochondrial membrane marker (Figure 2.1A-
D). Cells lacking EHD1 displayed a highly extended mitochondrial network that had 
numerous elongated structures (Figure 2.1B,D) compared to mock-treated cells (Figure 
2.1A,C). To quantitatively measure the differences in the mitochondrial networks of 
mock-treated and EHD1-depleted cells, we used a plug-in on ImageJ that is specifically 
designed to measure the morphology of mitochondria, Mito Morphology Macro 
(http://imagejdocu.tudor.lu/doku.php?id=plugin:morphology:mitochondrial_morpholog
y_macro_plug-in:start). Data from multiple cells imaged in three separate experiments 
indicated that both the average mitochondrial size (Figure 2.1F) and average 
mitochondrial perimeter (Figure 2.1G) are significantly larger in EHD1-depleted cells. 
On the other hand, the average circularity is significantly decreased in EHD1-depleted 
cells, which indicates that less mitochondrial fission is occurring (Figure 2.1H). In order 
to demonstrate that the mitochondrial fragmentation was due to the EHD1-depletion 
rather than off-target effects, we performed rescue experiments by knocking down 




Figure 2. 1 
EHD1 is required for mitochondrial homeostasis. (A–D) RPE cells were either mock 
treated (A,C) or treated with EHD1 siRNA for 72 h (B,D) and immunostained for the 
mitochondrial membrane marker Tom20. C and D are images of higher magnitude to 
visualize mitochondrial elongation. (E) The efficacy of the EHD1-depletion for A–D is 
demonstrated by immunoblotting lysates from mock and EHD1-depleted RPE cells. 
(F–H) The Mito Morphology Macro plugin in ImageJ was used to quantify mean±s.d. 
for mitochondrial size, perimeter and circularity, in three independent experiments 
each using 10 cells per treatment. *P<0.05 (one-tailed Student's t-test). Used with 
permission from JCS (Farmer et al., 2017). 
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cells (Figure 2.2). As demonstrated (Figure 2.2A-F) and quantified (Figure 2.2G), EHD1-
depleted cells that were transfected with EHD1 were successfully rescued and displayed 
an average mitochondrial size that was significantly shorter than the knockdown cells 
and similar to the mock-treated cells. Overall, these data support the notion that EHD1 
is needed for mitochondrial homeostasis. Based on the data suggesting an increased 
mitochondrial length upon EHD1-depletion, we hypothesized that if EHD1 is a 
mediator of mitochondrial dynamics, then the absence of the protein should result in 
less dynamic or more static mitochondria compared to mock cells. To test this, we used a 
mitochondria-specific dye, Mitotracker Red, to follow mitochondria in living cells. As 
shown, in mock-treated cells, the mitochondria are highly dynamic and constantly 
undergoing fusion and fission (Figure 2.3A) Images were taken every 15 s for 5 min and 
the arrows highlight fission events occurring within the cell. In comparison, the EHD1-
depleted cells become very static with limited dynamic movement and visible fission 
events (Figure 2.3B). These live imaging experiments further support the idea that EHD1 
is required for normal mitochondrial fission.  
9.2 EHD1 likely functions upstream of Dyn2 and Drp1 
 To date, Drp1 is considered to be the major protein that regulates mitochondrial 
fission (Pitts, Yoon, Krueger, & McNiven, 1999; Santel & Frank, 2008; Taguchi, Ishihara, 
Jofuku, Oka, & Mihara, 2007). However, it has recently been determined that the GTPase 





Figure 2. 2 
The elongated mitochondrial phenotype is rescued when EHD1 is reintroduced 
into EHD1 knock-down cells. (A-F) RPE cells were Mock-treated (A, C, E) or treated 
with EHD1-siRNA (B, D, F) for 72 h. Some of the cover-slips containing Mock or 
EHD1 knock-down cells were further transfected with a siRNA-resistant GFP-Myc-
EHD1 cDNA (si-GFP-myc-EHD1) for the last 24 h (C-F). All cells were fixed and 
immunostained with antibodies against Tom20 (A-F). GFP-Myc-EHD1 transfected 
cells are seen in green, Bar, 10 μm. (G) At least 7 cells from each treatment (in 3 
independent experiments) in A-F were analyzed by Mito Morphology Macro plugin 
in ImageJ and the mean+/-s.d. for size of their mitochondria was plotted. * denotes p 
values of less than 0.05, and n.s. denotes differences that are not statistically 




Figure 2. 3 
Mitochondrial dynamics are impaired upon EHD1 depletion. Live imaging was 
performed on RPE cells incubated with Mitotracker Red and either mock treated (A) 
or treated with EHD1 siRNA for 72 h (B). 4-slice z-section images were taken every 15 
s for 5 min for each treatment, and compiled to a maximal projection image. The 
arrows depict examples of fission events in mock-treated cells. Used with permission 





the significant homology between EHD1 and dynamin (Daumke et al., 2007), and the 
fact that EHD1 is an ATPase involved in endosomal fission (Cai et al., 2013; Cai et al., 
2014; Deo et al., 2018; Jakobsson et al., 2011), we hypothesized that EHD1 directly 
mediates fission at the mitochondrial membrane. To answer this hypothesis, we used a 
STS assay to induce mitochondria fragmentation in either mock-treated or EHD1-
depleted cells. STS is a global kinase inhibitor that induces mitochondrial fission and 
fragmentation through the activation of Drp1 and Dyn2. If Drp1 or Dyn2 are absent 
from the cells, fragmentation does not occur when induced by STS (J. E. Lee et al., 2016). 
We therefore rationalized that if EHD1 plays a similar role to Drp1 and Dyn2 in 
mitochondrial fission, the absence of EHD1 would protect the cells from STS-induced 
mitochondrial fragmentation as well. Accordingly, mock-treated and EHD1-depleted 
cells were either treated with or without STS for 1 h. The cells were then immunostained 
with antibodies for Tom20 to visualize the mitochondria morphology. EHD1-depleted 
cells displayed a network of elongated mitochondria compared to mock-treated cells 
(compare Figure 2.4B to 2.4A). The mitochondria in the EHD1-depleted cells displayed a 
greater average size (Figure 2.4E) and perimeter (Figure 2.4F) but significantly decreased 
circularity (Figure 2.4G), consistent with Figure 1 data. As anticipated, mock-treated 
cells that were subject to STS treatment resulted in mitochondria that underwent fission 
and fragmentation (compare Figure 2.4B with 2.4A), and the STS-induced cells had 
significantly decreased average size (Figure 2.4E) and perimeter (Figure 2.4F), but 








Figure 2. 4 
EHD1 plays a regulatory role in mitochondrial fission. (A–D) RPE cells were either 
mock treated (A,B) or treated with EHD1 siRNA for 72 h (C,D), followed by 
incubation with STS for the last 1 h of treatment (B,D) or without the drug (A,C). (E–
G) The Mito Morphology Macro plugin in ImageJ was used for quantifying 
mean±s.d. for mitochondrial size, perimeter and circularity in three independent 
experiments each using 10 cells per treatment. *P<0.05; n.s., not statistically 






subject to STS treatment clearly resulted in fission and fragmentation of the 
mitochondria (Figure 2.4D), and the mitochondria size, perimeter, and circularity were 
not significantly different than the mock-treated cells subject to STS treatment (Figure 
2.4E-G). While we cannot completely rule out the possibility that EHD1 plays a direct 
role in mitochondrial fission, these data support the idea that EHD1 most likely acts 
upstream of Drp1 and Dyn2 in the process of mitochondrial fission.  
9.3 EHD1 and Rabankyrin-5 regulate the retromer control of mitochondrial 
homeostasis 
 Previous studies have identified VPS35, a component of the retromer cargo 
selection complex, as a key regulator of mitochondria homeostasis and PD (Kumar et al., 
2012; Struhal et al., 2014; W. Wang et al., 2017; W. Wang et al., 2016; Zimprich et al., 
2011). One recent model suggests that VPS35 is responsible for the transport of the 
ubiquitin ligase Mul1 to the mitochondrial membrane where Mul1 ubiquitinates the 
mitochondrial fusion protein, Mfn2, resulting in proteasomal degradation (Tang et al., 
2015) (see model, Figure 2.5A). Since our lab has previously described an interaction 
between EHD1, Rabankyrin-5, and the retromer complex, we hypothesized that EHD1 
depletion might interfere with Mul1 trafficking to the mitochondrial membrane. In this 
scenario, increased levels of Mfn2 on the mitochondrial membrane might skew the 
fusion-to- fission ratio, resulting in an elongated mitochondria phenotype. To test this 
hypothesis, we first tested whether or not EHD1 interacted with Mul1. As a positive 






  Figure 2. 5 
EHD1 interacts with Mul1. (A) Model for the potential role of EHD1 in regulating 
mitochondrial dynamics via Mul1. Under normal conditions, the ubiquitin ligase 
Mul1 is released from an interaction with VPS35 and the retromer components 
(including EHD1), and relocates to the mitochondrial membrane, where it 
ubiquitinates Mfn2, inducing its proteasomal degradation and promoting normal 
mitochondrial fission. Upon EHD1 depletion, Mul1 would be retained in association 
with VPS35 and the retromer, preventing Mfn2 degradation and thus enhancing 
mitochondrial membrane fusion. (B) GST pulldown from bovine brain cytosol was 
performed with GST only, a GST-tagged EH domain of EHD1 (GST–EH1) and GST–
EHD1. Eluates were immunoblotted with antibodies against MICAL-L1 (top panel), 
as a positive interactor with EHD1, and Mul1 (middle panel). GST fusion protein 
samples were immunoblotted with anti-GST (bottom panel). (C) Co-
immunoprecipitation (IP) of proteins from a HeLa cell lysate using anti-Mul1 
(αMul1), and immunoblotted with anti-Vps26 and anti-rabankyrin-5 antibodies. 25 
kDa immunoglobulin light chains detected by the secondary anti-light chain 
antibody are indicated in the bottom panel. Used with permission from JCS (Farmer 




the known EHD1 interaction partner MICAL-L1 from bovine brain cytosol (Figure 2.5B, 
top panel), consistent with our previous results (Sharma, Giridharan, et al., 2009). 
Additionally, the purified GST-EHD1 pulled down Mul1 from the bovine brain cytosol, 
whereas the GST and GST-EH1 were unable to (Figure 2.5B, middle panel). To further 
elucidate the relationship between EHD1, Rabankyrin-5, the retromer, and Mul1, we 
performed co-immunoprecipitation experiments with endogenous levels of proteins 
(Figure 2.5C). In these biochemical assays, we were able to show that an antibody 
against Mul1 pulled down a component of the retromer complex, VPS26, as anticipated. 
However, in the same experiment, we also showed that Mul1 pulled down Rabankyrin-
5 (Figure 2.5C), and low levels of EHD1 (data not shown). These experiments suggest 
that EHD1 and Rabankyrin-5 interact with Mul1 to mediate its transport to 
mitochondria, where it regulates Mfn2 degradation. 
 We rationalized that if Rabankyrin-5 and EHD1 are cooperating together with 
the retromer to transport Mul1 to the mitochondrial membrane, then depletion of 
Rabankyrin-5 should result in a phenotype similar to EHD1-depletion. To test this, RPE 
cells were depleted of Rabankyrin-5 and immunostained with Tom20 to analyze the 
mitochondrial-morphology compared to mock-treated cells. As demonstrated, 
Rabankyrin-5-depleted cells displayed an elongated network of mitochondria compared 
to mock-treated cells (compare Figure 2.6B to 2.6A). Quantification of three independent 
experiments showed that the average size and perimeter of Rabankyrin-5-depleted cells 







  Figure 2. 6 
Rabankyrin-5 mediates the interaction between EHD1 and Mul1, and its depletion 
induces an elongated mitochondrial network similar to that observed upon EHD1 
depletion. (A,B) RPE cells were either mock treated (A) or treated with rabankyrin-5 
siRNA for 72 h (B) and immunostained for the mitochondrial membrane marker 
Tom20. (C) The Mito Morphology Macro plugin in ImageJ was used for quantifying 
mean±s.d. for mitochondrial size, perimeter and circularity in three independent 
experiments each using 10 cells per treatment. *P<0.05 (one-tailed Student's t-test). 
(D) HeLa cells were either mock treated or treated with Rabankyrin-5 siRNA, lysed, 
and subjected to a GST–EHD1 pulldown, and immunoblotted with Mul1 (upper 
panel). The efficacy of the Rabankyrin-5-depletion is demonstrated by 
immunoblotting lysates from mock-treated and Rabankyrin-5-depleted cells (bottom 




significantly decreased in Rabankyrin-5-depleted cells (Figure 2.6C).  
Since the EHD1 and Mul1 interaction appeared less robust than that of 
Rabankyrin-5 and Mul1, and because EHD1 is a direct interaction of Rabankyrin-5 
(Zhang, Reiling, et al., 2012), we postulated that Rabankyrin-5 might potentially mediate 
the interaction between EHD1 and Mul1. To test this idea, we used lysates from mock-
treated or Rabankyrin-5-depleted cells in pulldowns using GST-EHD1 as bait. 
Incubation of mock-treated lysate with GST-EHD1 resulted in significant Mul1 being 
pulled down, whereas the GST alone did not (Figure 2.6D, top panel). However, 
efficiently depleting Rabankyrin-5 from lysates (Figure 2.6D, middle panel) and 
incubating it with GST-EHD1 resulted in very little Mul1 being pulled down (Figure 
2.6D, top panel), suggesting that Rabankyrin-5 mediates the interaction between EHD1 
and Mul1. 
 If the mitochondrial elongation phenotype observed upon EHD1- or Rabankyrin-
5-depletion is due to the stabilization of Mfn2 on the mitochondrial membrane, one 
would predict that the levels of Mfn2 would increase under these conditions compared 
to mock-treated cells. To test this idea, we depleted EHD1, Rabankyrin-5, or VPS35 and 
compared the protein expression of Mfn2, Drp1, and actin (loading control) to mock- 
treated cells. siRNA treatment of HeLa cells resulted in efficient depletion of all three 
proteins (Figure 2.7A, top panels, and quantified in Figure 2.7B-G), whereas actin levels 






  Figure 2. 7 
Depletion of EHD1, Rabankyrin-5 or VPS35 does not induce Mfn2 
accumulation. HeLa cells were either mock treated, or treated with EHD1, 
Rabankyrin-5 or Vps35 siRNA for 72 h. Depletion efficacy was validated by 
immunoblotting with antibodies against EHD1, Rabankyrin-5 and VPS35 (A; top 
three panels), and the effect of the siRNA was assessed with antibodies against Mfn2 
(A; second panel from the top), Drp1 (A; third panel from the top) and actin (A; 
bottom panel). (B–G) Densitometric quantification from three separate experiments. 






panels). However, no difference was observed in the protein expression level of Mfn2 or 
Drp1 (Figure 2.7A, middle two panels), and no major changes in the Drp1 association 
and/or distribution along mitochondria was noted (data not shown). Data from these 
experiments suggest that despite the ability of EHD1 and Rabankyrin-5 to interact with 
Mul1, accumulation of Mfn2 and/or Drp1 on the mitochondrial membrane was likely 
not the mechanism by which EHD1 and Rabankyrin-5-depletion induce elongated 
mitochondria.  
9.4 EHD1 and Rabankyrin-5 differentially regulate VPS35 to control mitochondrial 
fission 
 Our previous results were unable to validate the notion that VPS35 is responsible 
for regulating Mfn2 levels through Mul1. However, a recent study presents an 
alternative model by which VPS35 and the retromer affect mitochondrial homeostasis by 
interacting with Drp1. The model suggests that retromer-containing vesicles remove 
inactive Drp1 from the mitochondrial membrane, enabling active Drp1 to occupy the 
receptors on the mitochondria to mediate fission (W. Wang et al., 2017) (see model in 
Figure 2.8L). In this model, depletion or sequestration of VPS35 would impair fission 
and induce formation of elongated mitochondria. We therefore hypothesized that EHD1 
regulates VPS35 expression or localization. To test this, we immunoblotted lysates that 
were either mock-treated or EHD1-depleted (Figure 2.8A). Upon efficient EHD1- 
depletion (Figure 2.8A), there was a consistent reduction in VPS35 to approximately 50% 






  Figure 2. 8 
Depletion of EHD1 and Rabankyrin-5 results in reduced and sequestered VPS35, 
respectively. (A–D) HeLa cells were either mock treated, treated with EHD1 siRNA 
(A) or treated with rabankyrin-5 (Rank-5) siRNA (C) for 72 h and immunoblotted for 
VPS35, EHD1, Rabankyrin-5 and actin. The asterisk (in A) indicates reduced VPS35 
protein levels. (B,D) Quantification of protein levels from three independent 
experiments. *P<0.05 (one-tailed Student's t-test). (E–J) RPE cells were either mock 
treated (E,G,I) or treated with rabankyrin-5 siRNA for 72 h (F,H,J), and 
immunostained for VPS35 and the Golgi membrane marker GM130. Regions of 
interest were drawn with a dashed line around the GM130 Golgi stain (I,J) and 
superimposed in the merged images (E,F) and in the VPS35-stained images (G,H; 
note, the region of interest is not shown in G and H so the VPS35 distribution pattern 
can be observed more clearly). Scale bar: 10 μm. (K) ImageJ was used to quantify the 
mean±s.d. for fluorescence of VPS35 localized to the central Golgi region marked by 
the regions of interest in three independent experiments each using 10 cells per 
treatment. *P<0.05 (one-tailed Student's t-test). (L) Current working model showing 
the proposed mechanism for EHD1 regulation of mitochondrial dynamics. In this 
scenario, EHD1 might act in facilitating fission of vesicles that transport VPS35 from 
endosomes to the mitochondrial membrane. VPS35 might then interact with inactive 
Drp1, removing it from the mitochondrial membrane and facilitating the function of 
active Drp1 leading to mitochondrial fission. Thus, the absence of EHD1 might 
prevent this transport step and lead to elongated mitochondria. Used with 
permission from JCS (Farmer et al., 2017). 
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VPS35 (Figure 2.8A, asterisk, and quantified in 2.8B). Additionally, the levels of VPS26 
were tested and were similarly decreased when EHD1 was depleted. Moreover, these 
experiments support the idea that VPS35 and the retromer control mitochondrial fission 
by removing inactive Drp1, thus allowing fission by active Drp1 (Figure 2.8L).  
 We went on to test whether Rabankyrin-5 similarly affects VPS35 protein levels. 
To our surprise, Rabankyrin-5-depleted cells had no impact on VPS35 expression levels 
(Figure 2.8C, quantified in 2.8D), leading us to hypothesize that Rabankyrin-5 regulates 
VPS35 in a manner that is distinct from that of EHD1. One potential mechanism is that 
Rabankyrin-5 is needed for the trafficking of VPS35-positive endosomes to the inactive 
Drp1 on the mitochondrial membrane. We therefore argued that if Rabankyrin-5 does 
regulate the trafficking of VPS35, then depletion of Rabankyrin-5 should result in an 
altered VPS35 localization pattern. To test this, we depleted Rabankyrin-5 and compared 
the subcellular distribution of VPS35 to mock-treated cells using GM130 to mark the 
Golgi region as a reference point within the cell (Figure 2.8E-J). As demonstrated, 
Rabankyrin-5-depleted cells had a significant degree of sequestration of VPS35 in the 
Golgi region as compared to mock-treated cells (Figure 2.8, compare F and H to E and G; 
dashed region of interest are the Golgi, as marked by GM130 in I and J). To quantify this, 
we measured the VPS35 fluorescence localized to the Golgi region and found that it was 
significantly higher in the Rabankyrin-5-depleted cells compared to mock-treated cells 
(Figure 2.8K). Overall, these experiments support a model by which depletion of EHD1 
and Rabankyrin-5 lead to a reduced level of VPS35 or an altered VPS35 subcellular 
distribution, respectively. This in turn prevents VPS35 from being able to traffic to the 
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mitochondrial membrane to remove inactive Drp1, culminating in impaired fission, thus 
leading to the elongated network of mitochondria observed in these cells.  
10. SUMMARY AND CONCLUSIONS 
 Mitochondrial dynamics have long been correlated with their cellular functions 
and mitochondrial morphology appears along a continuum from a network of tubular 
structures to smaller fragmented membranes (Benard et al., 2006). Indeed, early 
observations of mitochondria found that upon activation of ATP synthesis, 
mitochondria displayed a smaller and more condensed phenotype (Hackenbrock, 1966). 
Additionally, mitochondrial fragmentation has been observed in patient fibroblasts that 
have altered energy production due to defects in respiratory chain subunits (Capaldi, 
Murray, Byrne, Janes, & Marusich, 2004; Koopman et al., 2005). Since mitochondrial 
dynamics are highly regulated, researchers have extensively studied mitochondrial 
fusion and fission and the proteins that regulate these processes. In particular, the role of 
fission was thought to be controlled by one GTPase, Drp1 (Bleazard et al., 1999; 
Labrousse et al., 1999). However, a recent study has shed new light on the mechanism of 
mitochondrial fission and has identified the GTPase Dyn2 in playing a sequential role to 
Drp1 to mediate cleavage of mitochondrial membranes (J. E. Lee et al., 2016). 
 In addition to the focus on the proteins carrying out the process of fission and the 
recent mechanism by which Drp1 and Dyn2 facilitate fission, exciting new studies have 
implicated a role for VPS35 and the retromer in PD and mitochondrial dynamics, 
forging a novel connection between endocytic regulatory complex and a non-endocytic 
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organelle (Follett, Bugarcic, Collins, & Teasdale, 2017; Follett et al., 2014; Kumar et al., 
2012; Sharma et al., 2012; Struhal et al., 2014; Tang et al., 2015; Vilarino-Guell et al., 2011; 
Zimprich et al., 2011). However, while the relationship between VPS35, mitochondrial 
dynamics, and PD is now irrefutable, the precise mechanism(s) by which VPS35 controls 
fusion or fission remains somewhat controversial.  
 In Chapter II, we identify a novel regulatory role for EHD1 as an effector of 
mitochondrial fission. We demonstrated that upon EHD1-depletion, the mitochondria 
become more elongated and static, similar to the phenotype upon Drp1-depletion or 
mutation (Benard et al., 2007). Since EHD1 is an ATPase with homology to the dynamin 
family of GTPases (Daumke et al., 2007; Melo et al., 2017), it raised the question as to 
whether EHD1 plays a role in mitochondria fission in a similar manner to Drp1 and 
Dyn2. However, no significant localization of EHD1 was observed with the 
mitochondrial membrane, reducing the likelihood that EHD1 plays a direct role in 
mitochondrial fission. In addition, upon STS treatment of EHD1-depleted cells, the 
mitochondria nonetheless underwent fragmentation,  as opposed to what occurs upon 
Drp1 or Dyn2 depletion (J. E. Lee et al., 2016). This suggests that the kinase inhibitor 
likely activates Drp1 and/or Dyn2 directly, bypassing the potential regulatory role 
carried out by EHD1. 
 Since it is unlikely that EHD1 directly regulates mitochondrial fission, we asked 
what could be the potential role of EHD1 upstream of Drp1 and Dyn2. Previous studies 
in our lab and others have linked EHD1 to the retromer complex (Gokool et al., 2007; 
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Zhang, Reiling, et al., 2012), suggesting the possibility that EHD1 somehow functions 
upstream of the mitochondrial fission proteins. One potential model suggests that 
VPS35 and the retromer regulate the transport of the ubiquitin ligase Mul1 to the 
mitochondria (Tang et al., 2015; Yun et al., 2014). In this model, if Mul1 and VPS35 lose 
their interaction, Mul1 traffics to the mitochondria, where it ubiquitinates the fusion-
promoting protein Mfn2. Ubiquitination of Mfn2 targets it for proteasomal degradation 
thus reducing the amount of fusion and leading to a more fragmented phenotype (Tang 
et al., 2015). While we did demonstrate that Mul1 interacts with EHD1, through the 
EHD1 interaction partner Rabankyrin-5, which also interacts with the retromer (Zhang, 
Reiling, et al., 2012), we did not find increased levels of Mfn2 upon depletion of EHD1, 
Rabankyrin-5, or VPS35 as would be anticipated if less proteasomal degradation occurs. 
This suggests that the interactions between EHD1, Rabankyrin-5, VPS35, and Mul1 are 
not the primary mechanism for the control of mitochondrial dynamics. 
    Another model has been proposed that VPS35 regulates mitochondrial 
dynamics by a different mechanism where VPS35-containing vesicles interact with 
inactive Drp1 on the mitochondrial membrane and remove the inactive Drp1. As a 
result, Drp1 receptors are freed up to bind to active Drp1 and promote fission of the 
mitochondria (W. Wang et al., 2017). In this model, loss or altered regulation of VPS35 in 
the absence of EHD1 could lead to impaired fission resulting in an elongated and static 
mitochondrial network. Indeed, we demonstrated that depleting EHD1 from cells 
resulted in a decrease in VPS35 protein levels. Surprisingly, Rabankyrin-5-depletion did 
not result in a decrease in VPS35 proteins levels similar to EHD1. However, when 
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Rabankyrin-5 was depleted, the subcellular localization of VPS35 was altered, providing 
a mechanism for the formation of elongated mitochondria that is different from EHD1. 
While our data suggest that EHD1 and Rabankyrin-5 play a regulatory function 
upstream of mitochondrial fission through VPS35, we cannot rule out other potential 
roles that EHD1 and Rabankyrin-5 may play in fission or fusion of mitochondria, 
including the possibility that EHD1 might serve (at least in part) as a direct 
mitochondrial membrane fission protein.  
 In summary, Chapter II highlights a new mechanism of regulation of 
mitochondrial dynamics and further strengthens the growing crosstalk between 
endocytic regulatory proteins and non-endocytic organelles. While no mutations or 
impaired expression of EHD1 or Rabankyrin-5 has been documented thus far in PD, 
expanding the knowledge of key regulators of mitochondrial dynamics is likely to shed 
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11. ABSTRACT  
 The Bcl-2 family member Bcl-xL is an anti-apoptotic protein that plays a critical 
role in whether a cell lives or dies by protecting the integrity of the mitochondrial outer 
membrane (MOM). Bcl-xL works through a mechanism in which it prevents pore 
formation at the MOM but how Bcl-xL is recruited to the MOM is not fully understood. 
The retromer is a conserved endosomal scaffold complex involved in membrane 
trafficking. In Chapter III, we identify two core components of the retromer, VPS35 and 
VPS26, as novel regulators of the recruitment of Bcl-xL to the MOM. We observed 
interactions and colocalization between Bcl-xL, VPS35, VPS26, and MICAL-L1, the latter 
a protein that regulates tubular recycling endosomes and also interacts with the 
retromer. We also discovered that if VPS35 is depleted from cells, the levels of Bcl-xL 
that remain unassociated with MOM were significantly increased. Our results from this 
study suggest that the retromer regulates apoptosis by facilitating Bcl-xL’s transport to 
the MOM. Importantly, this chapter suggests a novel, previously uncharacterized 
relationship between machinery controlling apoptosis and endosomal trafficking.  
12. INTRODUCTION 
 Apoptosis is an essential cellular event that is required for normal development 
and the maintenance of tissue homeostasis, protection from genomic instability and 
mutation, and the control of humoral immune responses (Slomp & Peperzak, 2018). The 
Bcl-2 family of proteins consists of apoptosis regulators that are either pro-apoptotic 
(Bax, Bak, Bad, etc.) or anti-apoptotic (Bcl-2, Bcl-xL, Mcl-1, etc.) proteins (Adams & Cory, 
1998; Farrow & Brown, 1996; Fuchs & Steller, 2015). On one hand, interference with the 
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key regulators of apoptosis may lead to uncontrolled cell growth and pathologies that 
include breast (Placzek et al., 2010; Tawfik, Kimler, Davis, Fan, & Tawfik, 2012) and lung 
(Han et al., 2002; Viard-Leveugle, Veyrenc, French, Brambilla, & Brambilla, 2003) cancer, 
as a result of decreased cell death. On the other hand, increased cell death can lead to 
neurodegenerative disorders such as Alzheimer’s (Crews, Patrick, Adame, Rockenstein, 
& Masliah, 2011; M. H. Lee et al., 2010) and PD (Barcia et al., 2011; Berry, La Vecchia, & 
Nicotera, 2010). Bcl-xL is a vital anti-apoptotic protein that is up-regulated in a variety of 
cancers and increases the cell’s resistance to undergo apoptosis (Choi et al., 2016; Scherr 
et al., 2016). While Bcl-xL can function through a number of mechanisms, the main mode 
of action is sequestering the pro-apoptotic proteins Bax and Bak, thus preventing the 
formation of pores in the MOM and subsequent release of cytochrome c that activates 
caspases and downstream death signals (Oltvai, Milliman, & Korsmeyer, 1993; Shimizu 
et al., 1995; Yang et al., 1995). Bcl-xL mainly localizes to the MOM but also is partially 
localized to the cytoplasm before reaching the MOM (Hausmann et al., 2000; Y. T. Hsu, 
Wolter, & Youle, 1997; Nijhawan et al., 2003). While the signals that recruit Bcl-xL are 
unclear, some cellular signals result in the recruitment of Bcl-xL to the mitochondria (Y. 
T. Hsu et al., 1997), suggesting that Bcl-xL translocation from the cytosol to the 
mitochondria might be an important regulatory step in the apoptotic cascade. Clues to 
how Bcl-xL might be translocated to the mitochondria can be found in previous studies 
that have addressed other Bcl-2 family members. For example, Bax undergoes simple 
diffusion from the cytoplasm to the mitochondria (Wolter et al., 1997) and given the 
homology between Bcl-xL and Bax, one possibility is that Bcl-xL also undergoes simple 
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diffusion to the MOM. However, few studies have addressed the mechanism by which 
Bcl-xL is translocated and targeted to the mitochondrial membrane to prevent Bax and 
Bak pore formation. 
 In addition to diffusion as a potential mechanism for Bcl-2 family member 
translocation from the cytosol to MOM, other mechanisms of transport might also 
contribute. One possibility is that endocytic membrane trafficking might account for 
some of the Bcl-xL translocation to the MOM. While endocytic regulatory proteins are 
primarily responsible for regulating the internalization, sorting, and recycling of 
proteins and lipids from the PM (Naslavsky & Caplan, 2018), recent studies suggest that 
endocytic membrane trafficking proteins are responsible for a variety of non-endocytic 
cellular events, such as mitochondrial fission (Farmer et al., 2017; J. E. Lee et al., 2016) 
and centriole disengagement/duplication (Xie et al., 2018). For example, EHD1 is a key 
regulator of receptor recycling to the plasma membrane (Caplan et al., 2002; Guilherme 
et al., 2004) and also regulates both mitochondrial fission (Farmer et al., 2017) and 
centriole disengagement (Xie et al., 2018). Furthermore, the endocytic scaffolding 
complex known as the retromer, consisting of VPS26, VPS29, and VPS35, and two 
sorting nexin proteins, has also been implicated in mitochondrial fission (Farmer et al., 
2017; Naslavsky & Caplan, 2018; Tang et al., 2015; W. Wang et al., 2017) and centriole 
disengagement (Xie et al., 2018). The retromer subunit, VPS35, also directly interacts 
with and regulates multiple mitochondrial fission and fusion factors including the E3 
ligase Mul1 (Braschi et al., 2010; Tang et al., 2015) and the fission factor, Drp1 (Farmer et 
al., 2017; Tang et al., 2015; W. Wang et al., 2017). Interestingly, Bcl-xL and Drp1 interact 
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and colocalize on clathrin-associated vesicles (Li et al., 2013), suggesting a potential 
control mechanism for Bcl-xL by endocytic regulatory proteins. Accordingly, we 
hypothesized that VPS35 and the retromer interact with Bcl-xL and control the 
translocation of Bcl-xL from the cytosol to the MOM, thus influencing apoptosis. 
In Chapter III, we address whether the retromer and endocytic trafficking directs Bcl-xL 
translocation from the cytoplasm to the MOM. We demonstrate for the first time that 
Bcl-xL physically interacts with the retromer components VPS35 and VPS26 in a Drp1-
independent manner. Furthermore, the retromer and Bcl-xL colocalize on vesicles that 
are distinct from mitochondria. Significantly, the depletion of VPS35, which disrupts 
retromer function, results in reduced Bcl-xL on mitochondria and increases the rate of 
STS-induced apoptosis. While only a portion of the Bcl-xL seems to rely on the retromer 
to translocate to the MOM, our studies suggest a previously uncharacterized pathway 
for delivering Bcl-xL to the MOM that potentially has a significant consequence if 
disrupted.    
13. MATERIALS AND METHODS 
13.1 Reagents and antibodies 
 Staurosporine was purchased from Sigma Aldrich (S5921). Z-valine-alanine-
aspartic acid-(OMe)-fluromethylketone (Z-VAD) was purchased from Fisher Scientific 
(MP Biomedical; MP3FK00901). Commercial antibodies with their specific use (IB, 
immunoblotting; IF, immunofluorescence; and IP, immunoprecipitation) and catalogue 
numbers are indicated. Anti-VPS26 (IB, IF, IP, ab23892), anti-VPS35 (IB, ab157220), anti-
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Bcl-xL (IB, IP, ab32370), anti-Bcl-xL (IF, ab26035), anti-Parp1 (IB, ab137653), and anti-
Rab5 (IF, ab18211) were from Abcam; anti-DRP1 (IB, 611112) was from BD Cell Analysis; 
anti- MICAL-L1 (IB, IF, MBS9215151) was from MyBioSource; anti-Tom20 (IF, sc-11415) 
was from Santa Cruz Biotechnology; anti-EEA1 (IF, #3288) was from Cell Signaling; and 
anti-GAPDH-HRP (IB, HRP-60004) was from Protein Tech; donkey anti-mouse 
immunoglobulin (IgG) light chain–HRP (IB, 715-035-151) and mouse anti-rabbit IgG 
light chain–HRP (IB, 211-032-171) were from Jackson; mouse anti-rabbit IgG heavy 
chain–HRP (IB, ab99702) was from Abcam; donkey anti-mouse 488 (IF,A21202), donkey 
anti-mouse 568 (IF, 21043), goat anti-rabbit 488 (IF, A11034), goat anti-rabbit 568 (IF, 
A11036), and goat anti-rabbit 633 (IF, A21070) were from Molecular Probes. 
13.2 Cell Culture 
 The HeLa cervical cancer cell line was obtained from ATCC and grown in high 
glucose DMEM containing 10% FBS, 1x penicillin-streptomycin (Invitrogen), and 2 mM 
glutamine. The immortalized retinal pigment epithelium (RPE) cell line from ATCC was 
gown in high glucose DMEM containing 10% FBS, 1x penicillin-streptomycin 
(Invitrogen), 2 mM glutamine, and 2 mM non-essential amino acids. The CRISPR/Cas9 
HCT 116 cells lacking endogenous Bak and Bax, with GFP-tagged Bax knocked in (GFP-
Bax HCT 116) have been previously described (K. L. O'Neill, Huang, Zhang, Chen, & 
Luo, 2016)) and were grown in McCoy’s medium containing 10% FBS, 1× penicillin-
streptomycin (Invitrogen), and 2 mM glutamine.  
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13.3 Transfection and siRNA treatment 
 Transfection of RPE cells for 24 h at 37°C was performed using Fugene6 
(Promega) according to the manufacturer’s protocol. Smart-pool ON-Target Drp1, 
VPS35, and MICAL-L1 oligonucleotides were obtained from Dharmacon. RPE, HeLa, or 
GFP-Bax HCT 116 cells were transfected using Dharmafect 1 transfection reagent 
(Dharmacon) with 40 nM oligonucleotide. The knockdown efficiency of the protein was 
measured at 72 h post-transfection by immunoblotting for each experiment. 
13.4 Plasmids 
 mCherry-TOMM20 was a gift from Michael Davidson (Addgene; plasmid 
#55146). 
13.4 Co-immunoprecipitation 
 HeLa cells were grown in 100-mm dishes until confluent. Cells were lysed with 
lysis buffer containing 50 mM Tris, pH 7.4, 100 mM NaCl, 0.5% Triton X-100, and 1× 
protease cocktail inhibitor (Millipore) on ice for 30 min. Lysates were incubated with 
anti–Bcl-xL, anti-VPS26, or anti–MICAL-L1 antibody at 4°C overnight. Protein G beads 
(GE Healthcare) were added to the lysate-antibody mix at 4°C for 4 h. Samples were 
then washed three times with the same lysis buffer. Proteins were eluted from the 
protein G beads by boiling in the presence of 4× loading buffer (250 mM Tris, pH 6.8, 8% 
SDS, 40% glycerol, 5% β-mercaptoethanol, 0.2% bromophenol blue) for 10 min. Eluted 




 Cells were washed twice in ice-cold 1x PBS and then scraped off plates with a 
rubber policeman into ice-cold lysis buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 0.5% TX-
100, 1× protease cocktail inhibitor [Millipore]). Protein levels of post-nuclear lysates were 
quantified using the Bradford assay (BioRad) for equal protein level loading. For 
immunoblotting, 20–30 μg of protein per lysate (from either HeLa, RPE1, or GFP-Bax 
HCT 116 cells) was separated by SDS–PAGE. Proteins were transferred onto 
nitrocellulose membranes, and blocked for 30 min at room temperature in 1x PBST plus 
5% nonfat dry milk. The membranes were then incubated overnight at 4°C or for 1 h at 
room temperature with primary antibodies diluted in 1x PBST. Membranes were then 
washed three times with 1x PBST and incubated at room temperature with appropriate 
secondary antibodies diluted in 1x PBST for 30 min. The membranes were then washed 
again three times with 1x PBST, before enhanced chemiluminescence was used to detect 
the proteins. 
13.6 Mitochondrial enrichment 
HeLa cells were grown in 100-mm dishes and subject to either Mock- or VPS35-
siRNA treatment for 72 h. Cells were homogenized in buffer containing 150 mM NaCl, 
10 mM Tris, pH 6.8, 10 mM KCl, and 1 M sucrose. Homogenates were incubated with 
anti-Tom20 and rotated at room temperature for 10 min. Homogenates plus anti-Tom20 
were added to Dynabeads Protein G (Invitrogen) and rotated for 10 min at room 
temperature. The samples were placed on the magnet and the supernatant was collected 
for the non-mitochondrial fraction. The Dynabeads or mitochondrial fraction was 
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washed three times with the cell homogenization buffer. The beads and supernatant 
were subject to lysis in equal volumes with lysis buffer containing 50 mM Tris, pH 7.4, 
100 mM NaCl, 0.5% Triton X-100, and 1× protease cocktail inhibitor (Millipore) on ice for 
30 min. Loading buffer (4×) was added to each fraction and boiled for 10 min. Equal 
volumes were separated by SDS–PAGE and proteins were detected by immunoblotting 
with anti–Bcl-xL and anti-Tom20 antibodies. 
13.7 Quantification of immunoblots 
 The adjusted relative density of the immunoblots was measured in Fiji ImageJ 




 RPE or GFP-Bax HCT 116 cells were treated as indicated in the text and then 
fixed in 4% paraformaldehyde in 1x PBS for 10 min at room temperature. Cells were 
then washed three times in 1x PBS. The cells were then incubated with primary antibody 
in staining buffer (1x PBS containing 0.5% bovine serum albumin (BSA) and 0.2% 
saponin) for 1 h at room temperature, washed three times in 1x PBS and then incubated 
with the appropriate fluorochrome-conjugated secondary antibodies diluted in staining 
buffer for 30 min. Cells were washed three times in 1x PBS and mounted on microscope 
slides with Fluoromount. 
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Using a Zeiss LSM800 confocal microscope with a 63×/1.4 NA oil objective, z-
stack confocal images were collected. The series of images from a z-stack was then 
processed into a 3D projection, and a 3D snapshot was obtained using the Zeiss Zen 
Software. Similarly, 3D rotational videos were generated from the same 3D projections 
using the Zeiss Zen Software. For quantification, collected 3D snapshots were imported 
into Fiji ImageJ as described below. 
13.9 Colocalization quantification 
 Colocalization between mCh-TOMM20 and Bcl-xL, VPS26 and Bcl-xL, VPS26 
and mCh-TOMM20, Bcl-xL and Rab5, or Bcl-xL and EEA1 were assessed in Fiji ImageJ. 
Multichannel 3D snapshots were split into separate channels. A region of interest was 
drawn around individual cells in one of the two channels, using the “freehand” tool. 
This region was then subject to the colocalization threshold plugin, and colocalization 
was measured and calculated. 
13.10 Bax activation assay 
 GFP-Bax HCT 116 cells were subject to either Mock- or VPS35-siRNA treatment. 
In the last 60 min of the siRNA treatment, the cells were treated with 1 μM staurosporine 
(Sigma Aldrich). Cells were immunostained with anti-Tom20 as previously described. 
250 cells per treatment were designated as either having inactive (cytoplasmic) Bax or 
active (punctate) Bax. 
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13.11 Parp1 cleavage assay 
 GFP-Bax HCT 116 cells were subject to Mock- or VPS35-siRNA treatment. The 
cells were detached using trypsin and treated with 1 μM staurosporine for 0, 30, or 60 
min while continuously being rotated at 37°C. Immunoblotting was performed on the 
samples with anti-Parp1. The amount of full-length Parp1 was quantified by the method 
described above. 
13.12 Statistics 
 Data from Fiji ImageJ were imported into Microsoft Excel. The mean and the 
standard deviation of the mean were calculated from data obtained from three 
independent experiments with at least 10 images taken per treatment. Statistical 
significance was calculated using a Student’s t test with the Vassarstats program 
(http://www.vassarstats.net). 
14. RESULTS 
14.1 Bcl-xL resides in a protein complex with endocytic proteins and DRP1 
 Bcl-xL localizes to the MOM where it regulates apoptosis, but a pool of the 
protein can been observed in the cytoplasm (Hausmann et al., 2000; Y. T. Hsu et al., 
1997; Nijhawan et al., 2003). Previous studies suggest a diffusion mechanism for some 
Bcl-2 family members from the cytosol to the MOM, where the proteins become 
immobilized (Wolter et al., 1997). For example, conformational changes and homo-
oligomerization of the pro-apoptotic protein, Bax, lead to the exposure of mitochondrial 
targeting sequences within four of the protein’s nine helices (N. M. George, Targy, 
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Evans, Zhang, & Luo, 2010). However, despite the importance of Bcl-xL in preventing 
apoptosis, the specific mechanism of how it is translocated from the cytoplasm to the 
MOM remains poorly understood. Recent studies demonstrate the role of membrane 
trafficking in protein delivery to the MOM (Farmer et al., 2018; Farmer et al., 2017; Tang 
et al., 2015; W. Wang et al., 2017); accordingly, we hypothesized that a population of Bcl-
xL might also be regulated by endocytic membrane trafficking proteins. 
 We first tested whether Bcl-xL could be found in a complex with other endocytic 
regulatory proteins. Given the established interaction between Bcl-xL and Drp1 (Li et al., 
2013), and between Drp1 and the retromer complex, (W. Wang et al., 2017; W. Wang et 
al., 2016) and the growing number of trafficking pathways regulated by the retromer 
(Farmer et al., 2018; Farmer et al., 2017; Tang et al., 2015; W. Wang et al., 2017), we tested 
if Bcl-xL interacted with the retromer complex. As demonstrated, antibodies to VPS26 
immunoprecipitated detectable levels of endogenous VPS26 protein (Figure 3.1A; low 
and medium exposures), as well as endogenous Drp1 (Figure 3.1A; high exposure) and 
endogenous Bcl-xL (Figure 3.1A; low and medium exposures). Antibodies to Bcl-xL 
pulled down endogenous Bcl-xL (Figure 3.1A; low and medium exposures), as well as 
VPS26 (Figure 3.1A; low and medium exposures) and Drp1 (Figure 3.1A; high 
exposure), whereas control immunoglobulins (Ctl) did not pull down any detectable 
VPS26, Bcl-xL, or Drp1. Furthermore, immunoprecipitation with antibodies against 
MICAL-L1, an endocytic regulatory protein that interacts with the retromer (Zhang, 







Figure 3. 1 
Bcl-xL resides in a protein complex with members of the retromer and DRP1. (A) 
HeLa cell lysates were subjected to immunoprecipitations with anti-VPS26, anti–Bcl-
xL, or control IgG, and immunoblotted with antibodies against Drp1, VPS26, and 
Bcl-xL. Three different exposures of the same immunoblot are depicted: low, 
medium, or high exposure. Gels depicted are representative of three independent 
experiments showing similar results. Densitometric analysis from these experiments 
shows that 1) compared with the level of VPS26 precipitated with anti-VPS26 
(defined as 100%), 41–66% of VPS26 precipitates with anti–Bcl-xL, and 2) the level of 
DRP1 precipitated by anti–Bcl-xL ranges from ∼50 to 90% of that precipitated by 
anti-VPS26. (B) HeLa cell lysates were subjected to immunoprecipitations with anti–
Bcl-xL, anti–MICAL-L1, or control IgG, and immunoblotted with antibodies against 
MICAL-L1, VPS35, VPS26, and Bcl-xL. Gel depicted is representative of three 
individual experiments showing similar results. Densitometric analysis from these 
experiments shows that 1) the ratio of VPS26:Bcl-xL precipitated with anti–Bcl-xL is 
0.660+/− 0.110, which is very similar to the ratio of VPS35:Bcl-xL precipitated with 
anti–Bcl-xL (0.6866+/− 0.169), and 2) the ratio of VPS26:MICAL-L1 precipitated with 
anti–MICAL-L1 (0.589+/− 0.215) is similar to the ratio of VPS35:MICAL-L1 
precipitated with anti–MICAL-L1 (0.607+/− 0.129). (C) Efficacy of DRP1 depletion is 
demonstrated by immunoblotting lysates from Mock- or DRP1-depleted HeLa cells 
with anti-DRP1, and using GAPDH as a loading control. (D) Densitometric 
quantification of DRP1 protein levels in either Mock- or DRP1-siRNA treatment. 
Error bars denote SD. p values were determined by the Student’s one-tailed t test. n = 
3. (E) HeLa cells were treated with either Mock- or DRP1-siRNA, 
immunoprecipitated with antibodies against Bcl-xL, and immunoblotted with 
antibodies against VPS35, VPS26, and Bcl-xL. Gel depicted is representative of three 
individual experiments showing similar results. (F) Densitometric quantification of 
VPS35 or VPS26 protein levels immunoprecipitated by anti–Bcl-xL in the presence or 
absence of DRP1. Error bars denote SD. p values were determined by the Student’s 
one-tailed t test. n = 3. Used with permission from MBoC (Farmer et al., 2019). 
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proteins (Figure 3.1B). These experiments support the idea that Bcl-xL partially resides 
in a protein complex containing the retromer complex and MICAL-L1. 
 Since Drp1 interacts with both Bcl-xL and the retromer complex, we next asked 
whether Drp1 mediates the interaction between Bcl-xL and the retromer. To answer this 
question, HeLa cells were depleted of Drp1 by siRNA transfection (Figure 3.1C, 
quantified in 3.1D), and the Drp1 lysate was used to perform a pull down with 
antibodies against Bcl-xL. As anticipated, anti-Bcl-xL was able to pull down endogenous 
Bcl-xL in the mock- and Drp1-depleted lysates (Figure 3.1E, quantified in 3.1F). 
However, upon depletion of Drp1, anti-Bcl-xL still pulled down VPS26 and VPS35 
subunits (Figure 1E, top and middle panels, quantified in F). Similar to the anti-Bcl-xL 
pull down, depletion of VPS26, which led to a concomitant reduction of VPS35, did not 
prevent the pull down of Drp1 by Bcl-xL (data not shown). Overall, these experiments 
support the notion that Bcl-xL interacts with the retromer complex and MICAL-L1 in a 
Drp1-independent manner. 
14.2 Bcl-xL localizes to endocytic vesicles positive for the retromer 
 Since Bcl-xL interacts with several subunits of the retromer complex and 
interaction partners of the retromer, we hypothesized that the retromer serves as a 
regulator of Bcl-xL translocation from the cytosol to the MOM. Given that the ratio of 
Bcl-xL in the cytoplasm versus the MOM-bound Bcl-xL does not change under apoptotic 
conditions (Wolter et al., 1997), any slight change in the balance of the cytosolic-to-
mitochondrial Bcl-xL might be physiologically important. Accordingly, we postulated 
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that if a pool of Bcl-xL was translocated to the MOM by the retromer complex, we would 
visualize Bcl-xL associated with retromer-positive vesicles. To test this, we transfected 
RPE cells with mCherry-tagged Tom20 N-terminal 10 residues as a mitochondrial 
membrane marker and then sequentially immunostained the cells with antibodies 
against endogenous Bcl-xL and VPS26 (Figure 3.2 and 3D images in Figure 3.3). As 
demonstrated, populations of Bcl-xL were observed on VPS26-positive vesicles (Figure 
3.2A, inset in B, E, and H), and interestingly, these vesicles are almost completely devoid 
of the Tom20 MOM marker. However, most of the Bcl-xL was seen colocalized with the 
Tom20 and devoid of the VPS26 staining (Figure 3.2A, inset C, E, and F). When 
quantified, approximately 65% of the Bcl-xL was localized with mitochondria while less 
than 30% was on VPS26-positive vesicles (Figure 3.2D). Furthermore, endogenous 
VPS35 displayed approximately 85% overlap with VPS26 as expected, as well as ~25% 
colocalization with Bcl-xL (Figure 3.4). To further characterize what type of endosomes 
these were, we also stained the cells for Rab5 and EEA1, two early endosome markers, 
and observed nearly 20% of the Bcl-xL with Rab5, but little or no colocalization was seen 
with EEA1 (Figure 3.5). These data illustrate for the first time a population of Bcl-xL that 
localizes with a subset of endosomal vesicles that contain the retromer and Rab5, further 
suggesting the possibility that retromer plays a role in translocation of Bcl-xL to the 
MOM.  







  Figure 3. 2 
Bcl-xL localizes to endocytic vesicles containing the retromer. (A) RPE1 cells were 
transfected with the N-terminal 10 residues of the mitochondrial outer membrane 
protein (Tom20) tagged with mCherry (mCh-Tom20; red), and immunostained with 
VPS26 (blue) and Bcl-xL (green). Images shown are 3D snapshots of serial z-sections. 
Channels were split, showing the individual protein localization patterns (right 
panels). Regions of interest are highlighted with dashed boxes labeled as 1 or 2, and 
they correspond to the inset images depicted in B and C. Scale bar = 10 μm. (B) Inset 
area 1 from A. Arrows denote vesicles containing VPS26 (blue) and Bcl-xL (green) 
but lack mCh-Tom20 (red). Channels were split, showing the individual protein 
localizations. Scale bar = 2 μm. (C) Inset area 2 from A. Dashed circles show areas 
where Bcl-xL (green) is colocalized with mCh-Tom20 (red), but not VPS26 (blue). 
Channels were split, showing the individual protein localizations. Scale bar = 2 μm. 
Images portrayed are representative of three independent experiments (quantified in 
D). (D) The colocalization threshold analysis tool in Fiji ImageJ was used to quantify 
the colocalization between Bcl-xL and mCh-Tom20, Bcl-xL and VPS26, or mCh-
Tom20 and VPS26. Data are presented as a mean, and error bars indicate SD. n = 3. 
(E) A single representative RPE1 cell transfected with mCh-Tom20 (red), and 
immunostained with VPS26 (blue) and Bcl-xL (green). The image shown is a 3D 
snapshot of serial z-sections. Blue arrows depict VPS26 and Bcl-xL colocalization, 
whereas yellow arrows depict Bcl-xL and Tom20 colocalization. Scale bar = 10 μm. 
(F–H) Individual two-channel images from E are shown depicting the colocalization 
between Tom20 and Bcl-xL (F), VPS26 and Tom20 (G), and between Bcl-xL and 







  Figure 3. 3 
Bcl-xL and VPS26 localize to common vesicles. RPE1 cells were fixed, 
permeabilized and immunostained with antibodies to detect endogenous VPS26 
(green) and endogenous Bcl-xL (red). Serial z-sections were obtained every 0.4 μm 
and a 3D rotation was made from the 8 micrographs (see Video 1). The top image 
represents the initial micrograph prior top rotation, with arrows marking several Bcl-
xL and VPS26-containing vesicles. The middle and bottom images denote rotations 
of 45 and 180 degrees, respectively, and arrows mark the same vesicles seen in the 







Figure 3. 4 
Bcl-xL localizes to endocytic vesicles containing VPS35. (A) RPE1 cells were 
immunostained with antibodies against VPS26 (green) and VPS35 (red) and serial z-
sections were obtained. The images depicted are 3D snapshots. Dashed regions of 
interest correspond to the insets on the 3 right-hand panels. Inset channels were split, 
showing the individual protein localization patterns with white arrows depicting 
vesicles containing VPS26 and VPS35 containing vesicles. Scale Bar= 10 μm, (2 μm; 
inset). (B) RPE1 cells were immunostained with antibodies against Bcl-xL (green) and 
VPS35 (red) and serial z-sections were obtained. The images depicted are 3D 
snapshots. Dashed regions of interest correspond to the insets on the 3 right-hand 
panels. Inset channels were split, showing the individual protein localization 
patterns with white arrows depicting vesicles containing Bcl-xL and VPS35 
containing vesicles. Scale Bar= 10 μm, (2 μm; inset). (C) The co-localization threshold 
analysis tool in FIJI ImageJ was used. Data is presented as a mean, and error bars 







Figure 3. 5 
Bcl-xL localizes to Rab5-containing vesicles. (A) 3D snapshot of RPE1 cells 
immunostained with antibodies against Bcl-xL (red) and Rab5 (green). The dashed 
region of interest corresponds to the inset to the right. Arrows in the inset depict 
vesicles containing Bcl-xL (red) and Rab5 (green). Scale Bar= 10 μm, (2 μm; inset). 
(B) 3D snapshot of RPE1 cells immunostained with antibodies against Bcl-xL (red) 
and EEA1 (green). The dashed region of interest corresponds to the inset to the 
right. Scale Bar= 10 μm, (2 μm; inset). (C) The co-localization threshold analysis tool 
in FIJI ImageJ was used to quantify the co-localization between Bcl-xL and Rab5 and 
between Bcl-xL and EEA1. Data is presented as a mean, and error bars indicate 
standard deviation. n=3. 
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 The retromer is a scaffold and endocytic membrane complex responsible for the 
trafficking of a variety of proteins including the mannose 6-phosphate receptor, iron 
transporter DMT1-11/Slc11a2, and the Wnt transport protein Wntless/MIG-14 (Arighi et 
al., 2004; Eaton, 2008; Tabuchi et al., 2010). In each case, interference with retromer 
function leads to mislocalization (Eaton, 2008; Tabuchi et al., 2010) or occasionally to 
reduced expression levels of its cargo, possibly due to degradation (Arighi et al., 2004). 
Given that the these cargos are mislocalized or degraded when the retromer is 
dysfunctional, we hypothesized that if the retromer is responsible for trafficking Bcl-xL, 
we should see an impact on Bcl-xL localization or levels when the retromer is disrupted. 
In order to test this, we treated RPE cells with siRNA specific for VPS35 or the retromer 
interaction partner, MICAL-L1, and compared the Bcl-xL to cells that were mock-
treated. Depletion of VPS35 did not have an impact on the total Bcl-xL protein levels 
(data not shown). However, mock-treated cells displayed the majority of Bcl-xL on 
mitochondria (Figure 3.6, top panel, quantified in B), while VPS35- or MICAL-L1-
depleted cells (Figure 3.6C and D) had significantly more observable non-mitochondria 
associated Bcl-xL (Figure 3.6, middle and bottom panels [Bcl-xL in red]). Moreover, 
depletion of VPS35 led to an increased ratio of non-mitochondria associated Bcl-xL as 
determined by immunoblotting mitochondrial enriched fragments (Figure 3.6E, 
quantified in Figure 3.6F). Further testing did not suggest that the non-mitochondrial 
Bcl-xL observed when depleting VPS35 or MICAL-L1 was interacting with any 






  Figure 3. 6 
Loss of VPS35 or MICAL-L1 leads to increased non-mitochondrial Bcl-xL. (A) 
RPE1 cells were subjected to Mock-, VPS35-, or MICAL-siRNA, immunostained with 
antibodies against Tom20 (green) and Bcl-xL (red), and serial z-sections were 
obtained. The images depicted are 3D snapshots. Dashed regions of interest 
correspond to the insets in the three right-hand panels. Inset channels were split, 
showing the individual protein localization patterns. Scale bar = 10 μm, (2 μm; inset). 
(B) Quantification of the mean number of non-mitochondrial-associated Bcl-xL 
structures upon Mock-, VPS35-, and MICAL-L1-siRNA treatment. Error bars denote 
SD. p values were determined by the Student’s one-tailed t test. n = 3. (C) Efficacy of 
the VPS35-depletion is demonstrated by immunoblotting lysates from Mock- or 
VPS35-depleted RPE1 cells, with GAPDH as a loading control. (D) Efficacy of 
MICAL-L1-depletion is demonstrated by immunoblotting lysates from Mock- or 
MICAL-L1–depleted RPE1 cells using GAPDH as a loading control. (E) HeLa cells 
were treated with either Mock- or VPS35-siRNA, homogenized, and subject to 
immunofractionation with anti-Tom20 to generate an enriched mitochondrial 
fraction (Mt) and a non-mitochondrial fraction (Non-Mt). The fractions were 
separated by SDS–PAGE and immunoblotted with anti–Bcl-xL and anti-Tom20. (F) 
Densitometric quantification of the ratio of non-mitochondrial Bcl-xL vs. 
mitochondrial Bcl-xL in either Mock- or VPS35- siRNA treatment. Error bars denote 
SD. p values were determined by the Student’s one-tailed t test. n = 3. Used with 




oligomerize (Basanez et al., 2001; J. W. O'Neill, Manion, Maguire, & Hockenbery, 2006), 
it is possible that Bcl-xL remains in cytoplasmic aggregates as previously observed 
(Jeong et al., 2004) but further testing would need to be done to confirm this notion. 
Overall, these experiments support the idea that VPS35 and the retromer must be 
functional and is at least partially responsible for the translocation of Bcl-xL from the 
cytoplasm to the MOM and loss of the retromer leads to increased non-mitochondria 
associated Bcl-xL. 
14.4 VPS35-depleted cells display an enhanced rate of apoptosis 
 Under normal physiological conditions, the pro-apoptotic Bcl-2-family protein 
Bax is primarily localized to the cytoplasm and there is only a small percentage found on 
the MOM (Griffiths et al., 1999; Y. T. Hsu et al., 1997; Wolter et al., 1997). A key 
regulatory role of Bcl-xL is to sequester Bax in the cytoplasm and prevent its 
translocation to the mitochondrial membrane and/or bind to Bax associated with the 
MOM and prevent it from forming pores to release cytochrome c (Manon, Chaudhuri, & 
Guerin, 1997; Wolter et al., 1997; Yang et al., 1995). Another pro-apoptotic Bcl-2-family 
protein, Bad, is responsible for binding to Bcl-xL (Howells, Baumann, Samuels, & 
Finkielstein, 2011) and allowing Bax to freely translocate to the MOM where Bax can 
form pores and eventually lead to cell death (Bleicken et al., 2010; Gilmore, Metcalfe, 
Romer, & Streuli, 2000; Goping et al., 1998). Additionally, because Bcl-xL localized to the 
MOM has the ability to inhibit the formation of pores by dissociating oligomers or by 
preventing the insertion of Bax into the membrane (Subburaj et al., 2015; Xu et al., 2013), 
even a small decrease of Bcl-xL levels on the MOM could have a significant impact on 
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the regulation and rate of cell death. Based on our previous experiments, we 
hypothesized that VPS35 depletion decreases the amount of Bcl-xL on the MOM, thus 
increasing the rate of apoptosis. 
 To test this, we examined the recruitment of Bax to the MOM (punctate 
structures that form on the MOM and form pores) in VPS35 depleted cells as compared 
to mock-treated cells in the presence of the kinase inhibitor and apoptosis inducer 
(Belmokhtar, Hillion, & Segal-Bendirdjian, 2001), STS (Figure 3.7). In order to perform 
these experiments, we used CRISPR/Cas9 gene-edited HCT 116 cells that were depleted 
of endogenous Bax and Bak, but were stably transfected with GFP-tagged Bax (GFP-Bax) 
(K. L. O'Neill et al., 2016). GFP-Bax cells were treated mock- or VPS35-siRNA and were 
either given no treatment or treated with STS (Figure 3.7A-B). Efficacy of the siRNA 
treatment was verified in Figure 3.7C. Additionally, all cells were treated with Z-VAD to 
prevent the cells from undergoing complete apoptosis and detachment before we could 
image them. As anticipated, the GFP-Bax in the cells with no STS treatment displayed 
cytosolic GFP-Bax primarily, suggesting that the cells were not undergoing apoptosis 
and that Bax was not being recruited to the MOM (Figure 3.7A, left panels). However, 
upon STS treatment, although both the mock- and VPS35-siRNA treated cells showed 
recruitment of the GFP-Bax to the MOM from the cytoplasm (indicative of a cell 
undergoing apoptosis), VPS35 depleted cells showed a significantly higher rate of GFP-
Bax recruitment at the 60-min time point as compared to mock cells (Figure. 3.7A, right 






  Figure 3. 7 
The rate of Bax activation at the mitochondrial membrane is enhanced in cells 
lacking VPS35. (A) CRISPR/Cas9 HCT 116 cells lacking endogenous Bak and Bax, 
but expressing stably transfected GFP-Bax, were subject to Mock- or VPS35-siRNA 
knockdown, with or without staurosporine (STS) treatment for 60 min. Cells were 
fixed and immunostained with anti-Tom20 (red). For micrographs representing the 
STS treatment, only GFP-Bax is shown. Scale bar = 10 μm. (B) Quantification of the 
mean percentage of Mock- or VPS35-siRNA–treated cells displaying GFP-Bax 
activation upon STS treatment. Error bars represent SD. p value was determined by 
the Student’s one-tailed t test. n = 3. (C) Efficacy of the VPS35-siRNA treatment is 
demonstrated by immunoblotting lysates from Mock- or VPS35-depleted 
CRISPR/Cas9 HCT 116 cells with anti-VPS35. GAPDH was used as a loading control. 
(D) CRISPR/Cas9 HCT 116 cells lacking endogenous Bak and Bax, but expressing 
stably transfected GFP-Bax, were subject to either Mock- or VPS35-siRNA treatment 
for 48 h, and treated acutely with STS for 0, 30, or 60 min. Lysates from each 
treatment were analyzed by immunoblotting for Parp1 to assess cleavage over time, 
and immunoblotting with anti-VPS35 was used to verify the siRNA treatment 
efficacy. GAPDH was used as a loading control. (E) Densitometric representation of 
the data from D was done using ImageJ to calculate the ratio of Parp1:GAPDH 
between Mock- and VPS35-siRNA–treated cells. Data are presented as a mean, and 
error bars indicate SD. p values were determined by the Student’s one-




absence of VPS35, we performed biochemical assays to look at Parp1 cleavage (S. H. 
Kaufmann, Desnoyers, Ottaviano, Davidson, & Poirier, 1993; Tewari et al., 1995) at three 
different time points (Figure. 3.7D-E). Based on our previous experiment, as anticipated, 
we observed a significant increase in the rate of full-length Parp1 over 30-60 min of STS 
treatment compared to the mock-treated cells induced with STS (Figure. 3.7D-E). We 
verified the loss of full-length Parp1 by measuring the ratio of Parp1:GAPDH (loading 
control) and found a significant decrease in the full-length Parp1 in VPS35 depleted cells 
after 30 and 60 min of STS treatment compared to the mock-treated cells (Figure. 3.7E). 
These data are consistent with the idea that the retromer is at least partially responsible 
for translocating Bcl-xL to the MOM from the cytosol, and when VPS35 is depleted, the 
rate of apoptosis is enhanced due to Bcl-xL not being able to inhibit Bax appropriately.  
15. SUMMARY AND CONCLUSIONS 
 The tight control that Bcl-xL exerts over Bax-driven pore formation at the MOM 
and apoptosis hints at the significance of regulating its localization. Despite the crucial 
role of Bcl-xL in preventing apoptosis, although studies have addressed other Bcl-2-
family protein recruitment to the MOM (Desagher et al., 1999; Eskes, Desagher, 
Antonsson, & Martinou, 2000; Wolter et al., 1997) or Bcl-xL insertion into membranes 
(Adams & Cory, 1998; Y. T. Hsu et al., 1997; T. Kaufmann et al., 2003; Schinzel, 
Kaufmann, & Borner, 2004), to date few studies have addressed the mechanisms by 
which Bcl-xL is translocated to the MOM from the cytosol.  
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 In Chapter III, we identified a novel function for the retromer in partially 
controlling the translocation of Bcl-xL from the cytosol to the MOM where Bcl-xL then 
can prevent Bax pore formation. We demonstrated that Bcl-xL resides in a complex 
containing components of the retromer and MICAL-L1 in a Drp1-independent 
mechanism, along with observing vesicles that contained both Bcl-xL and the retromer 
or Rab5. Since Bcl-xL interacts and colocalizes with retromer-positive endosomes, it 
raises the question whether the retromer plays a role in regulating the localization of Bcl-
xL in the cell. To answer this, we depleted VPS35 from cells and demonstrated that 
cytosolic Bcl-xL was increased compared to the mock-treated cells, suggesting that less 
Bcl-xL was on the MOM to prevent apoptosis. To determine if the change in localization 
of Bcl-xL impacts its overall ability to prevent apoptosis, we induced apoptosis with STS 
in the presence or absence of VPS35. These data showed that when VPS35 is depleted, 
the rate of Bax recruited to the MOM is significantly faster and full-length Parp1 
cleavage occurs at a quicker rate, suggesting that VPS35 is at least partially responsible 
for controlling apoptosis through regulation of Bcl-xL translocation. 
 In summary, Chapter III describes a model in which disruption of the retromer 
complex by depleting VPS35 leads to reduced Bcl-xL at the MOM, causing enhanced 
Bax-mediated pore formation, cytochrome c release, and downstream apoptotic events 
upon STS treatment, and an enhanced rate of apoptosis (Figure. 3.8). Overall, this study 
highlights a novel role for the retromer, an endosomal protein complex, in the 
localization of Bcl-xL to the MOM, thus forging a link between endocytic regulation and 
apoptosis.   
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  Figure 3. 8 
Model for the role of retromer in regulating Bcl-xL’s translocation to the 
mitochondrial membrane and impact on staurosporine-induced apoptosis. Under 
physiological conditions (top), staurosporine treatment induces Bax translocation to 
the mitochondrial membrane. Because Bcl-xL is constitutively transported to the 
MOM, Bax pore formation is inhibited and slowed by Bcl-xL, but when sufficient Bax 
pore formation occurs, Cyt c is released and apoptosis occurs. Upon VPS35 
knockdown (bottom), there is impaired retromer complex generation and decreased 
constitutive transport of Bcl-xL to the MOM. Accordingly, upon staurosporine 
treatment there is less inhibition of Bax by Bcl-xL, leading to more rapid Bax pore 
formation and an increased rate of apoptosis. Used with permission from MBoC 


















 Overall, my work has uncovered several novel functions for endocytic regulatory 
proteins in non-classical endocytic pathways and on organelle biogenesis/homeostasis. 
In my first body of work, we demonstrated that EHD1 and Rabankyrin-5 play a role in 
mitochondrial homeostasis. Depleting EHD1 or Rabankyrin-5 results in mitochondria 
that are significantly longer and more interconnected, similar to what is observed upon 
Drp1- or Dyn2-depletion. Given that EHD1 is an ATPase with functional and structural 
homology to the Drp1 and Dyn2 GTPases, we hypothesized that EHD1 plays a direct 
role in mitochondrial fission alongside Drp1 and Dyn2. However, we did not observe 
significant localization of EHD1 to the mitochondrial membrane, and upon EHD1-
depletion, cells nevertheless underwent staurosporine-induced mitochondrial fission (as 
opposed to Drp1- and Dyn2-depletion). Prior studies had shown that VPS35, an 
interaction partner of EHD1 and Rabankyrin-5, plays a role in mitochondrial 
homeostasis through two potential pathways. The first one is by regulating the ubiquitin 
ligase Mul1. Mul1 interacts with VPS35 which must release Mul1 from this interaction in 
order to facilitate the trafficking of Mul1 to the mitochondrial membrane, where it 
ubiquitinates the fusion-promoting protein, Mfn2, and targets it for proteasomal 
degradation (Tang et al., 2015). If EHD1 and Rabankyrin-5 play a role in this pathway, a 
difference in Mfn2 protein levels would be expected upon EHD1- or Rabankyrin-5-
depletion. However, upon EHD1- or Rabankyrin-5-depletion, Mfn2 protein expression 
remained unchanged. This suggested that EHD1 and Rabnakyin-5 most likely play an 
upstream regulatory roles. The second potential mechanism by which VPS35 may 
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regulate mitochondrial homeostasis is by interacting with and removing inactive Drp1 
from the mitochondrial membrane and thus promoting mitochondrial fission by freeing 
up receptors for active Drp1 (W. Wang et al., 2017). Under this scenario, alterations in 
VPS35 function, potentially by depleting EHD1 or Rabankyrin-5, would result in 
impaired fission, resulting in an elongated and static mitochondrial network. Indeed, we 
demonstrated that upon EHD1-depletion, VPS35 protein levels were significantly 
reduced. Surprisingly, Rabankyrin-5-depletion did not result in the same reduction of 
VPS35 protein levels. However, we demonstrated that upon Rabankyrin-5 depletion, 
VPS35 becomes sequestered in the Golgi region. Regardless, in both cases, VPS35 was no 
longer capable of removing inactive Drp1 from the mitochondrial membrane, thus 
resulting in an elongated and static mitochondrial network. Overall, in this study we 
provide a mechanism by which EHD1 and Rabankyrin-5 play a regulatory role in 
mitochondrial fission upstream of Drp1 and Dyn2 by controlling VPS35 expression or 
localization, respectively. 
 In my second body of work, we found that the retromer plays a critical role in 
regulating the translocation of Bcl-xL to the mitochondrial membrane where it functions 
as an inhibitor of apoptosis. Despite the tight control that Bcl-xL exerts over Bax- and 
Bak-driven pore formation, few studies have previously studied the mechanisms by 
which it is translocated to the MOM. In this study, we demonstrated for the first time 
that Bcl-xL physically interacts with VPS35 and retromer subunits in a Drp1-
independent manner. Furthermore, the retromer and Bcl-xL colocalize on vesicles that 
are distinct from the Bcl-xL that colocalizes with mitochondria. Significantly, the loss of 
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VPS35 via siRNA both reduces the mitochondrial-localized Bcl-xL, and as a result, 
increases the rate of Bax activation and cleavage of Parp1 upon staurosporine-induced 
apoptosis. While our studies suggest that only a portion of Bcl-xL is translocated to the 
MOM by the retromer, given the significance of Bcl-xL in the regulation of apoptosis, 
this previously uncharacterized pathway for the delivery of Bcl-xL to the MOM may 
have potentially significant consequences. Our data supports a mechanism in which 
depletion of the retromer complex subunit VPS35 leads to reduced Bcl-xL at the MOM, 
causing enhanced Bax-mediated pore formation and Cyt c release upon staurosporine 
treatment, and an enhanced rate of apoptosis. Overall, this study highlights a novel role 
for the retromer, traditionally known as an endocytic regulatory protein complex, in the 
localization of Bcl-xL to the MOM, thus generating a link between endocytic regulation 
and apoptosis.  
17. FUTURE DIRECTIONS 
17.1 Chapter II future directions 
An increasing number of studies have begun to focus on the indirect regulation 
of mitochondrial homeostasis proteins, adding to the complexity of mitochondrial 
regulation in normal and disease state cells. Work from Chapter II further solidified the 
notion that endocytic regulatory proteins play a significant role in regulating 
mitochondrial fission. Specifically, EHD1 is responsible for stabilizing the protein 
expression of VPS35 and if EHD1 is depleted, VPS35 protein expression is significantly 
decreased. Previously, data published form our lab has identified a complex containing 
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the proteins EHD1, Rabankyrin-5, and the retromer components, VPS35 and VPS26 
(Zhang, Reiling, et al., 2012). However, whether the interactions between EHD1 and the 
retromer are direct or mediated via other proteins, such as Rabankyrin-5, has yet to be 
determined. Moreover, our data indicates that Rabankyrin-5-depletion has a similar 
impact on mitochondrial morphology to that of EHD1-depletion, suggesting that both 
proteins are needed to regulate inactive Drp1 removal from MOM by vesicles containing 
VPS35 and the retromer (Farmer et al., 2017). We have shown that EHD1 interacts 
directly with Rabankyrin-5, and we predict that EHD1 interacts indirectly with the 
retromer, likely mediated by Rabankyrin-5 or potentially another direct EHD1 
interaction partner such as MICAL-L1 or Syndapin2. First, to determine if the interaction 
between EHD1 and the retromer components, VPS26 and VPS35, is direct or indirect, we 
will use purified GST-EHD1 and HIS-tagged retromer proteins. A GST-pull down assay 
will be done incubating equimolar concentrations of purified GST-EHD1, with HIS-
VPS35 or HIS-VPS26. Immunoblotting of precipitated samples will be done. If, as 
anticipated, no direct binding is observed, we will first test whether the interaction is 
mediated by Rabankyrin-5. To accomplish this, Rabankyrin-5-depleted cells will be used 
to perform pull-downs with GST-EHD1 to determine whether retromer subunits fail to 
precipitate.  If the interaction of the upstream regulators of Drp1 can be elucidated, a 
better therapeutic approach can be used for controlling various disease states with 
upregulated Drp1 and therefore mitochondrial fission.  
 Additionally, it is believed that VPS35-containing mitochondrial-derived vesicles 
(MDVs) traffic inactive Drp1 from the mitochondrial membrane to the lysosome for 
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degradation, thus allowing active Drp1 and Dnm2 to catalyze fission. However, how 
these vesicles undergo fission from the MOM is currently unknown. Therefore, we 
predict that EHD1 will be needed to generate the MDVs required for Drp1 removal. To 
test this idea, we will use confocal microscopy to analyze changes in MDVs upon EHD1 
KD. Cells will be subjected to either mock- or EHD1-siRNA transfection. We will 
measure the number of MDVs containing Drp1 and/or VPS35 upon EHD1 KD. 
Observing significantly fewer MDVs in the absence of EHD1 will provide additional 
support for the notion that EHD1 is needed for the fission and generation of MDVs to 
traffic inactive Drp1 away from the mitochondria. 
17.2 Chapter III future directions 
To continue our work on chapter III, we will work to determine if Bcl-xL 
interacts directly with the retromer or if the interaction is mediated by other endocytic or 
apoptotic related proteins. By accomplishing this, we will gain insight into what other 
proteins are present with the retromer and Bcl-xL that may also be playing a role in the 
translocation of Bcl-xL to the MOM. For example, we might gain insight into the 
mechanism required for fission of the budding vesicle containing the retromer and Bcl-
xL, potentially by EHD1. In order to test this, we will use purified His-VPS35 or His-
VPS26 and GST-Bcl-xL to perform pull-down experiments. In the event that this 
experiment does not work, we will examine other potential candidates that might be 
mediating the interaction between the retromer and Bcl-xL. 
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 Furthermore, we will perform live-cell imaging to track the dynamics of the 
vesicles containing the retromer and Bcl-xL upon various treatments and conditions to 
see what impact they may have on the rate of Bax activation and apoptosis. In tandem 
with microscopic dynamic studies, single molecule imaging techniques, such as direct 
Stochastic Optical Reconstruction Microscopy (dSTORM) and/or electron microscopy 
will be used to perform a detailed analysis of the structure of the vesicles containing Bcl-
xL and retromer to gain further insight into the morphology and mechanism behind 
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